false --12-31 2023 Q3 0001448705 0001448705 2023-01-01 2023-09-30 0001448705 2023-11-15 0001448705 2023-09-30 0001448705 2022-12-31 0001448705 2023-07-01 2023-09-30 0001448705 2022-07-01 2022-09-30 0001448705 2022-01-01 2022-09-30 0001448705 us-gaap:CommonStockMember 2022-12-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001448705 us-gaap:RetainedEarningsMember 2022-12-31 0001448705 us-gaap:CommonStockMember 2023-03-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001448705 us-gaap:RetainedEarningsMember 2023-03-31 0001448705 2023-03-31 0001448705 us-gaap:CommonStockMember 2023-06-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001448705 us-gaap:RetainedEarningsMember 2023-06-30 0001448705 2023-06-30 0001448705 us-gaap:CommonStockMember 2021-12-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001448705 us-gaap:RetainedEarningsMember 2021-12-31 0001448705 2021-12-31 0001448705 us-gaap:CommonStockMember 2022-03-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001448705 us-gaap:RetainedEarningsMember 2022-03-31 0001448705 2022-03-31 0001448705 us-gaap:CommonStockMember 2022-06-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001448705 us-gaap:RetainedEarningsMember 2022-06-30 0001448705 2022-06-30 0001448705 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001448705 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001448705 2023-01-01 2023-03-31 0001448705 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001448705 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001448705 2023-04-01 2023-06-30 0001448705 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001448705 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001448705 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001448705 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001448705 2022-01-01 2022-03-31 0001448705 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001448705 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001448705 2022-04-01 2022-06-30 0001448705 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001448705 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001448705 us-gaap:CommonStockMember 2023-09-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001448705 us-gaap:RetainedEarningsMember 2023-09-30 0001448705 us-gaap:CommonStockMember 2022-09-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001448705 us-gaap:RetainedEarningsMember 2022-09-30 0001448705 2022-09-30 0001448705 us-gaap:ComputerEquipmentMember 2023-09-30 0001448705 us-gaap:ComputerEquipmentMember 2022-12-31 0001448705 us-gaap:MachineryAndEquipmentMember 2023-09-30 0001448705 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001448705 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2023-09-30 0001448705 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2022-12-31 0001448705 us-gaap:FurnitureAndFixturesMember 2023-09-30 0001448705 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001448705 us-gaap:LandImprovementsMember 2023-09-30 0001448705 us-gaap:LandImprovementsMember 2022-12-31 0001448705 us-gaap:SoftwareDevelopmentMember 2023-09-30 0001448705 us-gaap:SoftwareDevelopmentMember 2022-12-31 0001448705 us-gaap:ConstructionInProgressMember 2023-09-30 0001448705 us-gaap:ConstructionInProgressMember 2022-12-31 0001448705 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0001448705 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001448705 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001448705 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001448705 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-09-30 0001448705 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-12-31 0001448705 2022-01-01 2022-12-31 0001448705 2019-03-24 2019-03-25 0001448705 basa:FirstNewHavenMortgageCompanyLLCMember basa:UpstateCustomProductsLLCMember 2022-04-26 2022-04-27 0001448705 basa:FirstNewHavenMortgageCompanyLLCMember basa:UpstateCustomProductsLLCMember 2022-04-27 0001448705 basa:SmallBusinessAdministrationMember 2021-02-25 0001448705 basa:CommonStockWarrantsMember 2021-04-02 0001448705 basa:CommonStockWarrantsMember 2021-04-01 2021-04-02 0001448705 basa:CommonStockWarrantsMember 2021-04-09 0001448705 basa:CommonStockWarrantsMember 2021-04-08 2021-04-09 0001448705 basa:CommonStockWarrantsMember 2021-04-16 0001448705 basa:CommonStockWarrantsMember 2021-04-15 2021-04-16 0001448705 basa:CommonStockWarrantsMember 2023-09-30 0001448705 basa:CommonStockWarrants1Member 2021-04-16 0001448705 basa:CommonStockWarrants1Member 2021-04-15 2021-04-16 0001448705 basa:LiabilityInsurancePremiumsMember 2023-01-01 2023-09-30 0001448705 basa:LiabilityInsurancePremiumsMember 2023-09-30 0001448705 basa:LiabilityInsurancePremiumsMember 2022-12-31 0001448705 basa:PromissoryNoteMember 2022-08-31 0001448705 basa:PromissoryNoteMember 2022-08-30 2022-08-31 0001448705 basa:PromissoryNoteMember 2022-08-22 0001448705 basa:PromissoryNoteMember 2022-08-21 2022-08-22 0001448705 basa:PromissoryNote1Member 2022-08-22 0001448705 basa:PromissoryNote1Member 2022-08-21 2022-08-22 0001448705 basa:PromissoryNoteMember 2022-08-29 0001448705 basa:PromissoryNoteMember 2022-08-28 2022-08-29 0001448705 basa:PromissoryNote1Member 2022-08-29 0001448705 basa:PromissoryNote1Member 2022-08-28 2022-08-29 0001448705 basa:PromissoryNote1Member 2022-08-31 0001448705 basa:PromissoryNote1Member 2022-08-30 2022-08-31 0001448705 basa:PromissoryNoteMember 2022-08-01 0001448705 basa:PromissoryNoteMember 2022-07-30 2022-08-01 0001448705 basa:PromissoryNoteMember 2022-09-09 0001448705 basa:PromissoryNoteMember 2022-09-08 2022-09-09 0001448705 basa:PromissoryNote1Member 2022-09-09 0001448705 basa:PromissoryNote1Member 2022-09-08 2022-09-09 0001448705 basa:PromissoryNote2Member 2022-09-09 0001448705 basa:PromissoryNote2Member 2022-09-08 2022-09-09 0001448705 basa:PromissoryNote3Member 2022-09-09 0001448705 basa:PromissoryNote3Member 2022-09-08 2022-09-09 0001448705 basa:PromissoryNote4Member 2022-09-09 0001448705 basa:PromissoryNote4Member 2022-09-08 2022-09-09 0001448705 basa:PromissoryNoteMember 2022-09-22 0001448705 basa:PromissoryNoteMember 2022-09-21 2022-09-22 0001448705 basa:PromissoryNote1Member 2022-09-22 0001448705 basa:PromissoryNote1Member 2022-09-21 2022-09-22 0001448705 basa:PaulSallaruloMember basa:PromissoryNoteMember 2021-04-02 0001448705 basa:PaulSallaruloMember basa:PromissoryNoteMember 2021-04-01 2021-04-02 0001448705 basa:PaulSallaruloMember basa:PromissoryNoteMember 2022-04-01 2022-04-02 0001448705 basa:MichaelVBarberaMember basa:PromissoryNoteMember 2021-04-02 0001448705 basa:MichaelVBarberaMember basa:PromissoryNoteMember 2021-04-01 2021-04-02 0001448705 basa:MichaelVBarberaMember basa:PromissoryNoteMember 2022-04-01 2022-04-02 0001448705 basa:PromissoryNoteMember 2023-02-14 0001448705 basa:PromissoryNoteMember 2023-02-13 2023-02-14 0001448705 basa:PromissoryNoteMember 2023-02-24 0001448705 basa:PromissoryNoteMember 2023-02-23 2023-02-24 0001448705 basa:PromissoryNoteMember 2023-04-12 0001448705 basa:PromissoryNoteMember 2023-04-11 2023-04-12 0001448705 basa:PromissoryNoteMember 2023-04-28 0001448705 basa:PromissoryNoteMember 2023-04-27 2023-04-28 0001448705 basa:PromissoryNoteMember 2023-05-12 0001448705 basa:PromissoryNoteMember 2023-05-11 2023-05-12 0001448705 basa:PromissoryNoteMember 2023-06-05 0001448705 basa:PromissoryNoteMember 2023-06-04 2023-06-05 0001448705 basa:PromissoryNoteMember 2023-06-25 0001448705 basa:PromissoryNoteMember 2023-06-24 2023-06-25 0001448705 basa:PromissoryNoteMember 2023-09-11 0001448705 basa:PromissoryNoteMember 2023-09-10 2023-09-11 0001448705 basa:PromissoryNote1Member 2023-09-11 0001448705 basa:PromissoryNote1Member 2023-09-10 2023-09-11 0001448705 basa:SecuredConvertiblePromissoryNoteAgreementsWithRelatedPartyMember 2020-08-03 0001448705 basa:ConvertiblePromissoryNoteInvestorsMember 2021-02-12 0001448705 basa:ConvertiblePromissoryNoteInvestorsMember 2021-02-11 2021-02-12 0001448705 basa:ConvertiblePromissoryNoteInvestorsMember 2021-05-12 0001448705 basa:ConvertiblePromissoryNoteInvestorsMember 2021-05-01 2021-05-12 0001448705 basa:SecuredConvertiblePromissoryNoteMember 2022-09-15 0001448705 2022-09-01 2022-09-15 0001448705 basa:ConvertibleNotePayableMember 2023-07-01 2023-09-30 0001448705 basa:ConvertibleNotePayableMember 2023-01-01 2023-09-30 0001448705 basa:ConvertibleNotePayableMember 2022-07-01 2022-09-30 0001448705 basa:ConvertibleNotePayableMember 2022-01-01 2022-09-30 0001448705 basa:ConvertibleNotesPayableRelatedPartyMember 2023-09-30 0001448705 basa:ConvertibleNotesPayableRelatedPartyMember 2022-12-31 0001448705 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001448705 us-gaap:StockOptionMember 2021-12-31 0001448705 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0001448705 us-gaap:StockOptionMember 2022-03-31 0001448705 us-gaap:StockOptionMember 2022-04-01 2022-06-30 0001448705 us-gaap:StockOptionMember 2022-06-30 0001448705 us-gaap:StockOptionMember 2022-07-01 2022-09-30 0001448705 us-gaap:StockOptionMember 2022-09-30 0001448705 us-gaap:StockOptionMember 2022-12-31 0001448705 us-gaap:StockOptionMember 2023-01-01 2023-03-31 0001448705 us-gaap:StockOptionMember 2023-03-31 0001448705 us-gaap:StockOptionMember 2023-04-01 2023-06-30 0001448705 us-gaap:StockOptionMember 2023-06-30 0001448705 us-gaap:StockOptionMember 2023-07-01 2023-09-30 0001448705 us-gaap:StockOptionMember 2023-09-30 0001448705 us-gaap:StockOptionMember basa:ExercisePriceRangeOneMember 2023-01-01 2023-09-30 0001448705 us-gaap:StockOptionMember basa:ExercisePriceRangeOneMember 2023-09-30 0001448705 us-gaap:WarrantMember 2021-12-31 0001448705 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001448705 us-gaap:WarrantMember 2022-03-31 0001448705 us-gaap:WarrantMember 2022-04-01 2022-06-30 0001448705 us-gaap:WarrantMember 2022-06-30 0001448705 us-gaap:WarrantMember 2022-07-01 2022-09-30 0001448705 us-gaap:WarrantMember 2022-09-30 0001448705 us-gaap:WarrantMember 2022-12-31 0001448705 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001448705 us-gaap:WarrantMember 2023-03-31 0001448705 us-gaap:WarrantMember 2023-04-01 2023-06-30 0001448705 us-gaap:WarrantMember 2023-06-30 0001448705 us-gaap:WarrantMember 2023-07-01 2023-09-30 0001448705 us-gaap:WarrantMember 2023-09-30 0001448705 basa:ExercisePriceRangeOneMember us-gaap:WarrantMember 2023-01-01 2023-09-30 0001448705 basa:ExercisePriceRangeOneMember us-gaap:WarrantMember 2023-09-30 0001448705 basa:ExercisePriceRangeTwoMember us-gaap:WarrantMember 2023-01-01 2023-09-30 0001448705 basa:ExercisePriceRangeTwoMember us-gaap:WarrantMember 2023-09-30 0001448705 us-gaap:SubsequentEventMember 2023-11-08 2023-11-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

———————

FORM 10-Q

———————

 (Mark One)

 

  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: September 30, 2023

 

or

 

¨  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from: _____________ to _____________

 

Commission File Number: 000-53574

———————

Basanite, Inc.

(Exact name of registrant as specified in its charter)

———————

Nevada 20-4959207
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)

 

2660 NW 15th Court, Unit 108, Pompano Beach, Florida 33069

(Address of Principal Executive Office) (Zip Code)

 

(954) 532-4653

(Registrant’s telephone number, including area code)

 

_______________________________________________

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

———————

Securities registered pursuant to Section 12(b) of the Act: None.

  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   ¨ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes  ¨ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨   Accelerated filer   ¨
Non-accelerated filer        Smaller reporting company  
    Emerging growth company  ¨

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨ Yes   No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

 

Class Shares Outstanding as of November 15, 2023
     
Common Stock, $0.001 par value per share 259,156,796

 

  

 

 

 
 

 

 

BASANITE, INC. AND SUBSIDIARIES

 

TABLE OF CONTENTS

 

    Page No.
  PART I. – FINANCIAL INFORMATION  
     
Item 1. Condensed Consolidated Financial Statements  
  Condensed Consolidated Balance Sheets as of September 31, 2023 (Unaudited) and December 31, 2022 1
  Condensed Consolidated Statements of Operations (Unaudited) for the Three Months Ended September 30, 2023 and 2022 2
  Condensed Consolidated Statements of Stockholder’s (Deficit) Equity (Unaudited) for Three Months Ended September 30, 2023 and 2022 3
  Condensed Consolidated Statements of Cash Flows (Unaudited) for the Three Months Ended September 30, 2023 and 2022 5
  Notes to Condensed Consolidated Financial Statements (Unaudited) 6
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 20
Item 3. Quantitative and Qualitative Disclosures About Market Risk 27
Item 4. Controls and Procedures 27
     
  PART II. – OTHER INFORMATION  
     
Item 1. Legal Proceedings 28
Item 1A. Risk Factors 28
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28
Item 3. Defaults Upon Senior Securities 28
Item 4. Mine Safety Disclosures 28
Item 5. Other Information 28
Item 6. Exhibits  28
Signatures 29

 

 

 

 

 

2 
 

 

PART I. – FINANCIAL INFORMATION

 

ITEM 1.FINANCIAL STATEMENTS

 

BASANITE, INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

           
   September 30, 2023   December 31, 2022 
    (Unaudited)      
ASSETS          
           
CURRENT ASSETS          
Cash  $115,273   $30,340 
Accounts receivable, net   39,455    67,960 
Prepaid expenses   85,481    137,370 
TOTAL CURRENT ASSETS   240,209    235,670 
           
Lease right-of-use asset   80,724    153,270 
Fixed assets, net   434,233    530,238 
TOTAL NON CURRENT ASSETS   514,957    683,508 
           
TOTAL ASSETS  $755,166   $919,178 
           
           
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY          
           
           
CURRENT LIABILITIES          
Accounts payable  $1,764,146   $1,713,045 
Accrued expenses   878,066    438,870 
Accrued legal liability   165,000    165,000 
Subscription liability         1,300,000 
Notes payable   270,000    304,243 
Due to shareholders   475,000      
Notes payable - related party   1,575,000    605,000 
Notes payable - convertible - related party, net   2,144,357    2,144,357 
Lease liability – operating, current portion   80,724    93,186 
TOTAL CURRENT LIABILITIES   7,352,293    7,268,701 
           
Lease liability – operating, net of current portion         56,915 
           
TOTAL LIABILITIES   7,352,293    7,325,616 
           
STOCKHOLDERS’ (DEFICIT) EQUITY          
Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding            
Common stock, $0.001 par value, 1,000,000,000 shares authorized, 253,217,402 and 248,840,144 shares issued and outstanding, respectively   259,157    253,218 
Additional paid-in capital   48,824,620    47,433,354 
Accumulated deficit   (55,680,904)   (54,093,010)
TOTAL STOCKHOLDERS' (DEFICIT) EQUITY   (6,597,127)   (6,406,438)
           
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY  $755,166   $919,178 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

3 
 

 

BASANITE, INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(UNAUDITED)

 

 

                     
   For the three months ended   For the nine months ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Revenue                
Products sales - rebar  $49,140   $235,579   $317,664   $781,918 
                     
Total cost of goods sold   53,640    387,621    167,223    1,584,595 
                     
Gross (loss)   (4,500)   (152,042)   150,441    (802,677)
                     
OPERATING EXPENSES                    
Sales, general, and administrative   332,560    595,310    1,302,699    2,678,405 
Total operating expenses   332,560    595,310    1,302,699    2,678,405 
                     
NET LOSS FROM OPERATIONS   (337,060)   (747,352)   (1,152,258)   (3,481,082)
                     
OTHER INCOME (EXPENSE)                    
Liquidated damages – loan commitment                     (426,759)
Miscellaneous income         30          30 
Loss on extinguishment of debt                     (6,743,015)
Gain on loan forgiveness         170,096          170,096 
Interest expense   (162,529)   (84,467)   (435,636)   (388,701)
Total other income (expense)   (162,529)   85,659    (435,636)   (645,334)
                     
NET LOSS  $(499,589)  $(661,693)  $(1,587,894)  $(4,126,416)
                     
Net loss per share –                    
Basic  $(0.02)  $(0.00)  $(0.01)  $(0.02)
Diluted  $(0.02)  $(0.00)  $(0.01)  $(0.02)
                     
Weighted average number of shares outstanding –                    
Basic   259,156,796    253,187,772    259,156,796    251,736,069 
Diluted   259,156,796    253,187,772    259,156,796    251,736,069 

 

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

4 
 

 

 

BASANITE, INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

 

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

 

(UNAUDITED)

 

                          
           Additional       Total 
   Common Stock   Paid-in   Accumulated   Stockholders’ 
   Shares   Par Value   Capital   Deficit   Deficit 
Balance January 1, 2023   253,217,402   $253,218   $47,433,354   $(54,093,010)  $(6,406,438)
Warrants exercised for cash   —                           
Stock-based compensation   —            64,266          64,266 
Net loss   —                  (468,454)   (468,454)
                          
Balance March 31, 2023   253,217,402    253,218    47,497,620    (54,561,464)   (6,810,626)
                          
Stock issued for cash   3,939,394    3,939    1,296,061          1,300,000 
Net loss   —                  (619,851)   (619,851)
                          
Balance June 30, 2023   257,156,796    257,157    48,793,681    (55,181,315)   (6,130,477)
                          
Stock issued to management   2,000,000    2,000    30,939          32,939 
Net loss   —                  499,589    499,589 
                          
Balance September 30, 2023   259,156,796   $259,157   $48,824,620    (55,680,904)  $(6,597,127)

 

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

 

5 
 

 

BASANITE, INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (CONTINUED)

 

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

 

(UNAUDITED)

 

 

                          
                   Total 
                   Stockholders’ 
   Common Stock   Paid-in   Accumulated   Equity 
   Shares   Par Value   Capital   Deficit   (Deficit) 
Balance January 1, 2022   248,840,144   $248,842   $46,054,126   $(46,121,210)  $181,758 
                          
Stock issued for cash, net of costs of $50,409   2,121,212    2,121    647,470          649,591 
Stock issued for exercise of warrants   500,000    500    124,500          125,000 
Stock issued to service provider   300,000    300    57,600          57,900 
Warrants issued to management   —            169,565          169,565 
Net loss   —                  (1,520,661)   (1,520,661)
                          
Balance March 31, 2022   251,761,356    251,763    47,053,261    (47,641,871)   (336,847)
                          
Shares issued to related party for services   122,713    122    18,162          18,284 
Vesting of warrants issued to management   —            41,706          41,706 
Warrants issued to Related Party for services provided   —            64,264          64,264 
Net loss   —                  (1,944,062)   (1,944,062)
                          
Balance June 30, 2022   251,884,069    251,885    47,177,393    (49,585,933)   (2,156,655)
                          
Shares issued for exercise of warrants   1,333,333    1,333    98,667          100,000 
Warrants issued to service provider   —            157,294          157,294 
Net loss   —                  (661,693)   (661,693)
                          
Balance September 30, 2022   253,217,402   $253,218   $47,433,354   $(50,247,626)  $(2,561,054)

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

6 
 

 

BASANITE, INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

(UNAUDITED)

 

 

           
   For the nine months ended 
   September 30, 
   2023   2022 
   (Unaudited)     
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(1,587,894)  $(4,126,416)
Adjustments to reconcile net loss to net cash used in operating activities:          
Lease right-of-use asset amortization, operating lease   72,546   220,933 
Lease right-of-use asset amortization, financing lease        (1,725)
Lease right-of-use asset amortization, financing lease, related party        (705)
Depreciation and amortization   96,005    100,670 
Loan forgiveness        (170,096)
Stock-based compensation   97,205    509,013 
Changes in operating assets and liabilities:          
Prepaid expenses   51,889   (43,132)
Inventory        431,098 
Accounts receivable   (28,505   (57,917)
Deposits and other current assets         12,117 
Accounts payable and accrued expenses   517,297    1,159,268 
Subscription liability         1,300,000 
Lease liability, operating lease   (39,367   (238,595)
Lease liability, financing lease         (563)
Lease liability, financing lease – related party         (1,444)
Net cash used in operating activities   (820,824   (907,494
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of equipment         (780,476)
Proceeds from sale of equipment         450,000 
Net cash used in investing activities         (330,476 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from sale of common stock, net of costs         649,591 
Proceeds from exercise of warrants         225,000 
Proceeds from notes payable and notes payable related party   970,000    305,000 
Repayments of notes payable and notes payable related party   (64,234   20,158 
Net cash provided by financing activities   905,757    1,199,749 
           
NET (DECREASE) INCREASE IN CASH   84,233    (38,221)
           
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD   30,340    109,514 
           
CASH AND CASH EQUIVALENTS AT END OF PERIOD  $115,273   $71,293 
           
Supplemental cash flow information:          
Cash paid for income taxes   $       $    
Cash Paid for interest   $       $    
Forgiveness of Paycheck Protection Program loan and accrued interest  $     $167,996 
           
           
Supplemental disclosure of non-cash investing and financing activities:          
Accounts payable paid by financing lease, related party  $     $450,000
Extension of convertible note interest rolled in  $     $337,950 

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

 

7 
 

 

BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 1 – ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN

 

(A) Description of Business

 

Basanite, Inc., a Nevada corporation (the “Company”, “Basanite”, “we”, “us”, “our” or similar terminology), through our wholly owned subsidiary, Basanite Industries, LLC, a Delaware limited liability company (“BI”), manufactures a range of “green” (environmentally friendly), sustainable, non-corrosive, lightweight, composite products used in concrete reinforcement by the construction industry. Our core product is BasaFlex™, a basalt fiber reinforced polymer reinforcing bar (“rebar”) which we believe is a stronger, lighter, sustainable, non-conductive and corrosion-proof alternative to traditional steel.

 

Our two other main product lines are BasaMix™, which are fine denier basalt fibers available in various sizes, and BasaMesh™, a line of Basalt Geogrid Mesh Rolls, intended to replace welded wire mesh (made of steel) and other fiber reinforced polymer (“FRB”) grids and mesh.

 

BasaMix™ is designed to help absorb the stresses associated with early-aged plastic shrinkage and settlement cracking in concrete, as well as providing an increased toughness for enhanced reinforcement in Slab-on-Grade (“SOG”) and precast elements. BasaMix™ also serves in a “system approach” for optimum performance of a concrete element when used in conjunction with our BasaFlex™ rebar.

 

BasaMesh™ is designed for secondary and temperature shrinkage reinforcement. BasaMesh™ can also work in conjunction with the BasaFlex™ rebar or BasaMix™ for a total reinforcement program.

 

Each of our products is specifically designed to extend the lifecycle of concrete products by eliminating “concrete spalling.” Spalling results from the steel reinforcing materials embedded within the concrete member rusting (contrary to popular belief, concrete is porous and water can permeate into concrete). Rusting leads to the steel expanding and eventually causing the surrounding concrete to delaminate, crack, or even break off, resulting in potential structural failure. We believe that each Basanite product addresses this important need along with other key requirements in today’s construction market.

 

Manufacturing

 

We previously leased a fully permitted, 36,900 square foot facility located in Pompano Beach, Florida equipped with five customized, Underwriters Laboratories approved, Pultrusion manufacturing machines for BasaFlex™ production, plus other composite manufacturing equipment. Each Pultrusion machine has up to two linear production lines (we use one or two lines per machine depending on rebar size – giving a maximum capacity of 10 manufacturing lines). To date, BI’s operations team has successfully optimized and scaled the capacity of our manufacturing plant to produce up to 25,000 linear feet of BasaFlex™ rebar per shift, per day, depending on the product mix. BI’s own fully equipped test lab is utilized to evaluate, validate, and verify each product’s performance attributes. Depending on our manufacturing needs in the future, we have and may continue to explore alternative or additional manufacturing or corporate facilities. As of December 31, 2022, we no longer operate nor manufacture in our previous Pompano Beach facility.

 

To satisfy what we perceive the market interest for BasaFlex™ to be, and in particular to address potential large-scale customers like CPPB, we need to significantly accelerate the expansion of our manufacturing capacity. Our current goal is to locate a new manufacturing facility and restart our manufacturing operations and ultimately to reach a plant production capacity exceeding 73,000 linear feet per day per day on a two day shift basis (which would be 3 times our current capacity). To accomplish these goals, we have designed and developed customized pultrusion equipment which offers significantly increased capacity in the same footprint as our current equipment. Our new technology manufacturing system, named BasaMax™, has been specifically designed for the manufacture of BasaFlex™ using our patent pending process. Two versions of this equipment have been designed, and these will not only offer double the capacity of our current equipment (per machine), but also each will run at faster and more efficient rates. A prototype has completed thorough testing in our previous Pompano facility, including initial production runs, and is currently undergoing modifications and upgrades to the final production configuration.

Based on this trial, we are planning a two-phase plant expansion, eventually including a total of 10 of these new machines. Our goal, subject to raising sufficient funding of about 5 million dollars, is to have the first set of five of the new machines installed and be operational by the end of the second quarter of 2024 and to install and have operational five more, along with additional custom manufacturing equipment, by the fourth quarter of 2024 providing sales dictate for the 2025 production year. This would create the opportunity for BI to ultimately reach our production level target for the new facility by the end of the second quarter 2025. 

(B) Liquidity and Management Plans

 

Since inception, the Company has incurred net operating losses and used cash in operations. As of September 30, 2023, and December 31, 2022, respectively, the Company reported:

 

an accumulated deficit of $55,680,904 and $54,093,010.

 

a working capital deficiency of $7,112,084 and $7,033,031; and

 

cash used in operations of $820,824 and $907,494.

 

 

8 
BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

 

NOTE 1 – ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (CONTINUED)

 

Losses have principally occurred as a result of the substantial resources required for product research and development, establishment and upgrading of our manufacturing facility and equipment, and for certification, government approval and marketing of the Company’s products; including the general and administrative expenses associated with the organization.

 

While we have generated relatively little revenue to date, revenue from sales of product began to increase during the first half of 2023 (including the quarter ended September 30, 2023), and we continue to receive inquiries and solicit orders from a range of customers for our products, indicating what we believe is a significant level of market interest for BasaFlex™ and BasaMix™ products. We also spent time and resources during the first half of 2023 introducing our products to, and receiving approvals and certifications from, various county and local government agencies to have our products used in such agencies’ construction projects.

 

We have historically satisfied our working capital requirements through the sale of restricted Common Stock of the Company, $0.001 par value per share (the “Common Stock”), and the issuance of warrants to purchase Common Stock and promissory notes. Until we are able to internally generate meaningful revenue and positive cash flow, we will attempt to fund working capital requirements through third party financing, including through potential private or public offerings of our securities as well as bridge or other loan arrangements. However, a number of factors continue to hinder the Company’s ability to attract new capital investment. We cannot provide any assurances that the required capital will be obtained at all, or that the terms of such required capital may be acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. If we are unable to secure funding when needed, our results of operations may suffer, and our business may fail.

 

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties.

 

We have historically satisfied our working capital requirements through the sale of restricted common stock of the Company, $0.001 par value per share (the “Common Stock”), and the issuance of warrants to purchase Common Stock and promissory notes, some of which were or are convertible into shares of Common Stock. Until we are able to internally generate meaningful revenue and positive cash flow, we will attempt to fund working capital requirements through third party financing, including through potential private or public offerings of our securities as well as bridge or other loan arrangements. However, a number of factors continue to hinder the Company’s ability to attract new capital investment. We cannot provide any assurances that the required capital will be obtained at all, or that the terms of such required capital may be acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. If we are unable to secure funding when needed, our results of operations may suffer, and our business may fail.

 

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties.

 

At September 30, 2023, the Company had cash of $115,273 compared to $30,340 at December 31, 2022.

 

9 
BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

(A) Use of Estimates in Financial Statements

 

The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Stock-based compensation and stock awards related to convertible debt instruments are recognized based on the fair value of the awards granted. The fair value of each award or conversion feature is typically estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions, including the fair value of the underlying Common Stock, the expected term of the option, the expected volatility of the price of our Common Stock, risk-free interest rates and the expected dividend yield of our Common Stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.

 

The Company used the Black Scholes valuation model to determine the fair value of the warrants and options issued, using the following key assumptions for the nine months ended September 30, 2022. There were no such valuations during the nine months ended September 30, 2023:

        
   Nine months   Nine months 
   ended   ended 
   September 30,   September 30, 
   2023   2022 
   (Unaudited)     
Expected price volatility  N/A   144.21-145.773% 
Risk-free interest rate  N/A   2.55-4.21 
Expected life in years  N/A   5 
Dividend yield  N/A   N/A 

 

(B) Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of Basanite, Inc. and its wholly owned subsidiaries, Basanite Industries, LLC and Basalt America, LLC. All intercompany balances have been eliminated in consolidation. The Company’s operations are conducted primarily through Basanite Industries, LLC. Basalt America, LLC is currently inactive.

 

 

10 
BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

(C) Cash

 

The Company considers all highly liquid temporary cash instruments with an original maturity of three months or less to be cash equivalents. The Company places its cash, cash equivalents and restricted cash on deposit with financial institutions in the United States, which are insured by the Federal Deposit Insurance Company “(“FDIC”) up to $250,000. The Company’s credit risk in the event of failure of these financial institutions is represented by the difference between the FDIC limit and the total amounts on deposit. Management monitors the financial institutions' creditworthiness in conjunction with balances on deposit to minimize risk. The Company from time to time may have amounts on deposit in excess of the insured limits.

 

(D) Inventories

 

The Company’s inventories consist of raw materials, work in process and finished goods, both purchased and manufactured. Inventories are stated at lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. Raw materials inventory consists of basalt fiber and other necessary elements to produce BasaFlex™ rebar and our other products. On a quarterly basis, the Company analyzes its inventory levels and records allowances for inventory that has become obsolete and inventory that has a cost basis in excess of the expected net realizable value.

 

The Company’s inventory at September 30, 2023 and December 31, 2022 was (0) zero.

 

(E) Fixed assets

 

Fixed assets consist of the following:

          
   September 30,   December 31, 
   2023   2022 
    (Unaudited)      
Computer equipment  $203,193   $203,193 
Machinery   728,245    728,245 
Leasehold improvements            
Office furniture and equipment            
Land improvements            
Website development            
Construction in process            
    931,438    931,438 
Accumulated depreciation and amortization   (497,205)   (401,200)
   $434,233   $530,238 

 

Depreciation expense for the three and nine months ended September 30, 2023, was $31,962 and $96,005, respectively; depreciation expense for the three months and nine months ended September 30, 2022, was $33,919 and $100,670, respectively.

 

 

11 
BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

  

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

(F) Deposits and other current assets

 

The Company’s deposits and other current assets consist of the deposits made on equipment, security deposits, utility deposits and other receivables. The deposits are reclassified as part of the fixed asset cost when received and placed into service.

 

(G) Loss Per Share

 

The basic loss per share is calculated by dividing the Company’s net loss available to common shareholders by the weighted average number of common shares during the period. The diluted loss per share is calculated by dividing the Company’s net loss by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.

 

The following are potentially dilutive shares not included in the loss per share computation:  

          
   September 30,   December 31, 
   2023   2022 
    (Unaudited)      
Options   1,477,778    1,477,778 
Warrants   126,295,757    139,555,757 
Convertible securities   8,016,068    8,016,068 
Total   149,799,603    149,389,507 

 

(H) Stock-Based Compensation

 

The Company recognizes compensation costs to employees under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation – Stock Compensation. Under FASB ASC Topic 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the grant.

 

(I) Revenue Recognition

 

We recognize revenue when control of the promised goods or services is transferred to the Company’s customers in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. The timing of revenue recognition largely is dependent on shipping terms. Revenue is recorded at the time of shipment for terms designated free on board (“FOB”) shipping point. For sales transactions designated FOB destination, revenue is recorded when the product is delivered to the customer’s delivery site.

 

 

12 
BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

All revenues recognized are net of trade allowances, cash discounts, and sales returns. Trade allowances are based on the estimated obligations. Adjustments to earnings resulting from revisions to estimates on discounts and returns have been immaterial for each of the reported periods. Shipping and handling amounts billed to a customer as part of a sales transaction are included in revenues, and the related costs are included in cost of goods sold. Shipping and handling are treated as fulfillment activities, rather than promised services, and therefore are not considered separate performance obligations. During the three and nine months ended September 30, 2023, and 2022, the Company incurred shipping and handling costs in the amount of $1,026 and $40,254, respectively.

 

NOTE 3 – OPERATING LEASE

 

On January 18, 2019, the Company entered into an agreement to lease approximately 25,470 square feet of office and manufacturing space in Pompano Beach, Florida through March 2024. On March 25, 2019, the Company entered into an amendment to the agreement to increase the square footage of leased premises to 36,900 square feet, increasing the Company’s base rent obligation to be approximately $33,825 per month for one year and nine months, and increasing annually at a rate of three percent for the remainder of the lease term.

 

The right-of-use asset is composed of the sum of all remaining lease payments plus any initial direct costs and is amortized over the life of the expected lease term. For the expected term of the lease, the Company used the initial term of the five-year lease. If the Company does elect to exercise its option to extend the lease for another five years, for which the election will be treated as a lease modification, the lease will be reviewed for remeasurement.

 

On December 31, 2022 the Company and Landlord ended the lease agreement of the facility.

 

The future minimum lease payments to be made under the operating lease as of September 30, 2023, are zero.

 

On July 11, 2022, the Company entered into a sale leaseback transaction (the “Agreement”) with Quayco, LLC, a Pennsylvania limited liability company (the “Lessor”). The Company had previously ordered certain specialized BasaMax™ Pultrusion Machines (the “Machines”) from Upstate Custom Products LLC, a South Carolina limited liability company (the “Manufacturer”). The Machines are to be used to manufacture the Company’s basalt fiber reinforced polymer (BFRP) rebar products. Pursuant to the Agreement, the Lessor will pay the Company (Lessee) $450,000 and the Lessee will transfer to the Lessor secured rights to the ownership of one (1) BasaMax™ Tetrad Pultrusion Machine and all rights under the sales orders and agreements to purchase the Machines from Manufacturer. The Company had previously recorded this amount in accounts payable and construction in progress; at the date of the financing, the amount of $450,000 was transferred from construction in progress to a right of use asset and lease liability. The Company used a discount rate of 21% in calculating the lease liability and is the estimated rate the Company would be subject to for the financing of a similar equipment purchase. Pursuant to this lease, the Company will make payments in the amount of $8,250 per month for 24 months. 

 

 

13 
BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

 

 

NOTE 4 – FINANCING LEASE – RELATED PARTY

 

On April 27, 2022, the Company entered into an Equipment Rental Agreement (the “Agreement”) with First New Haven Mortgage Company, LLC, a Connecticut limited liability company and an affiliate of the Company (the “Lessor”). Ronald J. LoRicco, the Chairman of the Company’s Board of Directors, is the co-managing member of the Lessor and has an indirect pecuniary interest in the Lessor. In accordance with Nevada corporate law, the Agreement was independently reviewed and approved by the unanimous vote of the disinterested directors of the Company, with Mr. LoRicco recusing himself from voting.

 

Pursuant to the Agreement, the Lessor paid approximately $450,000 to Upstate Custom Products LLC, a South Carolina limited liability company (the “Manufacturer”) on April 22, 2022, to purchase a single, specialized BasaMax™ Tetrad Basalt Rebar Pultrusion Machine to be used to manufacture the Company’s products (the “Machine”). The Company had previously ordered the Machine from the Manufacturer, and pursuant to the Agreement, the Lessor secured rights to the ownership of the Machine and rights under all the sales orders and agreements to purchase the Machine from Manufacturer to the Lessor. The loan amount was paid directly to the Manufacturer. The Company used a discount rate of 21% in calculating the lease liability and is the estimated rate the Company would be subject to for the financing of a similar equipment purchase. Pursuant to this lease, the Company will make payments in the amount of $8,250 per month for 24 months, followed by a final payment in the amount of $450,000.

The Company has not yet received the machine in order to satisfy the transfer of the asset. As such, the $450,000 received from the transaction has been recorded as a liability on the balance sheet as of September 30, 2023 and December 31, 2022, respectively.

NOTE 5 – NOTES PAYABLE

 

Notes payable totaled an aggregate of $270,000 and $304,243 on September 30, 2023, and December 31, 2022, respectively. 

On February 25, 2021, the Company entered a promissory note agreement with a bank for $165,747 loan bearing an interest rate of 1.0% per annum. The loan was made pursuant to the Paycheck Protection Program under the Second Draw PPP Legislation after receiving confirmation from the U.S. Small Business Administration (“SBA”). The Paycheck Protection Program Flexibility Act requires that the funds be used to maintain the current number of employees as well as cover payroll-related costs, monthly mortgage or rent payments and utilities and not more than 40% can be expended on non-payroll-related costs. The applicable maturity date will be the maturity date as established by the SBA. If the SBA does not establish a maturity date or range of allowable maturity dates, the term will be five years. The Company applied for forgiveness of this loan on January 17, 2022; the Company received notice of forgiveness on August 1, 2022.

 

On April 2, 2021, the Company issued a promissory note with an investor in exchange for $200,000 bearing an interest rate of 18% per annum and payable in 1 year. The Company also issued 2,000,000 Common Stock warrants at an exercise price of $0.20 per share expiring in 5 years. As of September 30, 2023, the loan was extended to April 2, 2024.

 

On April 9, 2021, the Company issued a promissory note with an investor in exchange for $50,000 bearing an interest rate of 18% per annum and payable in 1 year. The Company also issued 500,000 Common Stock warrants at an exercise price of $0.20 per share expiring in 5 years. As of September 30, 2023 the loan was extended to April 9, 2024.

 

On April 16, 2021, the Company issued a promissory note with an investor in exchange for $25,000 bearing an interest rate of 18% per annum and payable in 1 year. The Company also issued 250,000 Common Stock warrants at an exercise price of $0.25 per share expiring in 5 years. As of the date of this report, the note has not been called. As of September 30, 2023 the loan was repaid in full and the balance is $0.

 

On April 16, 2021, the Company issued a promissory note with an investor in exchange for $20,000 bearing an interest rate of 18% per annum and payable in 1 year. The Company also issued 200,000 Common Stock warrants at an exercise price of $0.25 per share expiring in 5 years. As of September 30, 2023 the loan was extended to April 16, 2024.

 

The Company enters into financing arrangements for its liability insurance premiums. The financings have a term of one year and an interest rate of 9.40%. The balance due on these financings as of September 30, 2023 and December 31, 2022 $0 and $3,245, respectively.

 

Interest expense for the Company’s promissory notes payable for the three and nine months ended September 30, 2023 was, in the aggregate, $16,507 and $32,866, respectively, compared to $16,800 and $32,866 for the three and nine months ended September 30, 2022, respectively.

 

Accrued interest for the Company’s promissory notes payable on September 30, 2022 and December 31, 2022 was, in the aggregate, $147,062 and $101,391, respectively, and is included in accrued expenses on the accompanying condensed consolidated balance sheets.

 

14 
BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

 

NOTE 6 – NOTES PAYABLE – RELATED PARTY

 

Notes payable – Related Party, totaled an aggregate of $605,000 and $300,000 at September 30, 2022, and December 31, 2021, respectively.

 

On August 31, 2022 the Company issued a promissory note to a board member in exchange for $37,000 bearing an interest rate of 10% per annum and payable on August 31, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 31, 2024.

 

On August 22, 2022 the Company issued a promissory note to a board member in exchange for $20,000 bearing an interest rate of 10% per annum and payable on August 22, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 22, 2024.

 

On August 22, 2022 the Company issued a promissory note to a board member in exchange for $5,000 bearing an interest rate of 10% per annum and payable on August 22, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 22, 2024.

 

 

On August 29, 2022 the Company issued a promissory note to a board member in exchange for $25,000 bearing an interest rate of 10% per annum and payable on August 29, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 29, 2024.

 

On August 29, 2022 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 10% per annum and payable on August 29, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 29, 2024.

 

On August 31, 2022 the Company issued a promissory note to a board member in exchange for $13,000 bearing an interest rate of 10% per annum and payable on August 31, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 31, 2024.

 

On August 1, 2022 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 10% per annum and payable on August 1, 2024.

 

On September 9, 2022 the Company issued a promissory note to a board member in exchange for $60,000 bearing an interest rate of 10% per annum and payable on August 16, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 16, 2024.

 

On September 9, 2022 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 10% per annum and payable on September 9, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of September 9, 2024.

 

On September 9, 2022 the Company issued a promissory note to a strategic partner in exchange for $10,000 bearing an interest rate of 10% per annum and payable on September 9, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of September 9, 2024.

 

On September 9, 2022 the Company issued a promissory note to a strategic partner in exchange for $15,000 bearing an interest rate of 10% per annum and payable on September 9, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of September 9, 2024.

 

On September 9, 2022 the Company issued a promissory note to an investor and advisor to the board, in exchange for $15,000 bearing an interest rate of 10% per annum and payable on September 9, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of September 9, 2024.

 

On September 22, 2022 the Company issued a promissory note to a board member in exchange for $42,500 bearing an interest rate of 10% per annum and payable on March 22, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of March 22, 2024.

 

On September 22, 2022 the Company issued a promissory note to a board member in exchange for $42,500 bearing an interest rate of 10% per annum and payable on March 22, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of March 22, 2024.

 

On April 2, 2021, the Company issued a promissory note to Paul Sallarulo, a member of our Board of Directors, in exchange for $150,000 bearing an interest rate of 18% per annum and payable on April 2, 2022. The Company also issued a warrant to purchase 1,500,000 shares of Common Stock at an exercise price of $0.20 per share expiring in 5 years. On April 2, 2022, the due date of this note was extended to October 31, 2022. The note was extended for 2 additional years with a new maturity date of October 31, 2024.

 

15 
BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

 

NOTE 6 – NOTES PAYABLE – RELATED PARTY (CONTINUED)

 

On April 2, 2021, the Company issued a promissory note to Michael V. Barbera, our Chairman of the Board, in exchange for $150,000 bearing an interest rate of 18% per annum and payable on April 2, 2022. The Company also issued a warrant to purchase 1,500,000 shares of Common Stock at an exercise price of $0.20 per share expiring in 5 years. On April 2, 2022, the due date of this note was extended to October 31, 2022. The note was extended for 2 additional years with a new maturity date of October 31, 2024.

 

On February 14, 2023 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 20% per annum and payable February 14, 2024.

 

On February 24, 2023 the Company issued a promissory note to a board member in exchange for $50,000 bearing an interest rate of 20% per annum and payable February 24, 2024.

 

On April 12, 2023 the Company issued a promissory note to a board member in exchange for $150,000 bearing an interest rate of 20% per annum and payable April 11, 2024.

 

On April 28, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable April 27, 2024.

 

On May 12, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable May 11, 2024.

 

On June 5, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable June 4, 2023.

 

On July 25, 2023 the Company issued a promissory note to a board member in exchange for $200,000 bearing an interest rate of 20% per annum and payable on July 24, 2024.

 

On September 11, 2023 the Company issued a promissory note to a board member in exchange for $150,000 bearing an interest rate of 20% per annum and payable on September 10, 2024.

 

On September 11, 2023 the Company issued a promissory note to a board member in exchange for $50,000 bearing an interest rate of 20% per annum and payable on September 10, 2024.

 

During the three and nine months ended September 30, 2023, the Company made principal payments in the amount of $25,000 on notes payable.

 

Accrued interest for the Company’s notes payable - related party on September 30, 2022, and December 31, 2021, was an aggregate of $250,837 and $181,259, respectively, and is included in accrued expenses on the accompanying condensed consolidated balance sheets.

 

 

16 
BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

 

NOTE 7 – NOTES PAYABLE – CONVERTIBLE – RELATED PARTY (CONTINUED)

 

Convertible Notes payable – related party totaled an aggregate of $2,144,357 on September 30, 2023, and December 31, 2022 respectively.

 

On August 3, 2020, the Company issued a secured convertible promissory note to certain investors in exchange for $1,000,000 in the aggregate bearing an interest rate of 20% per annum and payable in 6 months. The holder may convert the unpaid principal balance of the note into shares of restricted Common Stock at the conversion price equal to $0.275 per share, which conversion price was set with the consummation of the Company’s private placement of Units which closed on August 17, 2021. This note contains a negative covenant that requires the Company to obtain consent prior to incurring any additional equity or debt investments and is secured by all of the assets of the Company. The Richard A. LoRicco Sr. and Lucille M. LoRicco Irrevocable Insurance Trust DTD 4/28/95, Louis Demaio as Trustee (the “Trust”) is the holder of $750,000 of the principal amount of this note. The Trust was created by Richard A. LoRicco Sr. and Lucille M. LoRicco, who were the parents of Ronald J. LoRicco Sr., the Chairman of the Company’s Board of Directors, and is maintained by an independent trustee. Ronald J. LoRicco Sr. does not have voting or investment control of or power over the Trust but is an anticipated, partial beneficiary of the Trust.

 

On February 12, 2021, the Company exchanged the original debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $1,610,005 bearing an interest rate of 20% per annum and fully payable in 3 months. This was accounted for as a debt extinguishment and the new promissory note was recorded at fair value in accordance with ASC 470 “Debt”. The original principal of $1,000,000 and accrued interest of $110,005 calculated as of the date of amendment and restatement along with an additional advance of $500,000 determined the principal amount of the new note. In consideration of the additional advance and the extension of the maturity date of the original note, the Company issued to the noteholders 5-year warrants to purchase an aggregate of 15,000,000 shares of Common Stock with an exercise price of $0.20 per share. The issuance of the warrants for the extension generated a loss on extinguishment of $3,686,123 for the fair value of the warrants issued.

 

On May 12, 2021, the Company extended the debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $1,689,746 bearing an interest rate of 20% per annum and fully payable February 12, 2022. The original principal of $1,610,005 and accrued interest of $79,742 calculated as of the date of amendment and restatement determined the principal amount of the new note. In consideration of the additional advance and the extension of the maturity date of the original note, the Company issued to the noteholders 5-year warrants to purchase an aggregate of 7,500,000 shares of Common Stock with an exercise price of $0.35 per share. The issuance of the warrants for the extension generated a loss on extinguishment of $1,874,705 for the fair value of the warrants issued.

 

On September 15, 2022, the Company extended the debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $2,027,695 bearing an interest rate of 20% per annum and fully payable February 12, 2023. The amended principal of $1,689,746 and accrued interest of $337,949 calculated as of the date of amendment and restatement determined the principal amount of the new note. No additional consideration was provided.

 

Interest expense for the Company’s convertible notes payable – related parties for the three and nine months ended September 30, 2023, was an aggregate of $107,218 and $321,654 respectively, compared to $45,371 and $276,228, respectively, for the three and nine months ended September 30, 2022.

 

Accrued interest for the Company’s convertible notes payable – related parties on September 30, 2023 and December 31, 2022, was an aggregate of $446,496 and $129,867, respectively, and is included in accrued expenses on the condensed consolidated balance sheets. 

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

The Company is the obligor under certain promissory notes that are currently past due (although formal events of default have not been declared).

 

The Company is presently in default of its obligations under the terms of the Company’s private placement which closed in August 2021 to file a registration statement for an underwritten public offering and concurrently listing on a national stock exchange. As a result, the Company is required to pay liquidated damages in the amount of $53,345 per month starting in March 2022, and the maximum amount of such liquidated damages could be approximately $480,000 if such filing is not made.

 

On August 17, 2021, the Company conducted the closing of a private placement offering to accredited investors of the Company’s units at a price of $0.275 per unit, with each unit consisting of: (i) one share of the Company’s common stock, (ii) a five-year, immediately exercisable warrant (“Warrant A”) to purchase one share of common stock at an exercise price of $0.33 per share and (iii) an additional five-year, immediately exercisable warrant to purchase one share of common stock at an exercise price of $0.33 per share (“Warrant B”). The Warrant A and Warrant B are identical, except that the Warrant B has a call feature in favor of the Company, as defined in the offering agreements. In connection with the closing, the Company entered into definitive securities purchase agreements with 19 accredited investors and issued an aggregate of 19,398,144 shares of common stock, Warrant A to purchase up to an aggregate of 19,398,144 shares of common stock, and Warrant B to purchase up to an aggregate of 19,398,144 shares of Common Stock (for an aggregate of 38,796,288 Warrant Shares), for aggregate gross proceeds to the Company of approximately $5,334,490. Costs of the offering in the amount of $611,603 were charge to additional paid in capital. As of December 31, 2022 the Company also accrued the amount of $386,759 as liquidated damages due to the investors in the Company’s August 2021 private placement, such liquidated damages being related to the Company’s failure to timely file a registration statement on Form S-1 for an underwritten public offering and concurrent listing of the Common Stock on a national exchange.

 

NOTE 9 – STOCKHOLDERS’ DEFICIT

 

During the nine months ended September 30, 2023, the Company issued 3,939,394 shares at $0.33 per share from subscription liabilities of $1,300,000 for cash that was received in a prior period.

 

 

17 
BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

 

 

 

NOTE 10 – OPTIONS AND WARRANTS

 

Stock Options:

 

The following table provides the activity in options for the respective periods:

 

               
   Total Options   Weighted Average   Aggregate Intrinsic 
   Outstanding   Exercise Price   Value 
             
Balance at December 31, 2021   4,227,778   $0.33   $19,500 
Exercised   (500,000)   0.25    —   
Cancelled / Expired   (1,000,000)   0.55    —   
Balance at March 31, 2022   2,727,778)  $0.26   $   
Cancelled / Expired   (1,000,000)   0.25      
Balance at June 30, 2022   1,727,778   $0.27   $   
Exercised              
Balance at September 30, 2022   1,727,778   $0.27   $   

 

   Total Options   Weighted Average   Aggregate Intrinsic 
   Outstanding   Exercise Price   Value 
             
Balance at December 31, 2022   4,227,778   $0.33   $6,798 
Issued   (20,000,000)   0.27    —   
Cancelled / Expired   (750,000)   0.27    —   
Balance at March 31, 2023   1,477,778)  $0.27   $  
Cancelled / Expired        0.27      
Balance at June 30, 2023   1,727,778   $0.27   $   
Exercised              
Balance at September 30, 2023   1,727,778   $0.27   $   

 

Options exercisable and outstanding at September 30, 2023 are as follows:

 

                    
Range of  Number   Weighted Average Remaining Contractual   Weighted Average   Aggregate 
Exercise Prices  Outstanding   Life (Years)   Exercise Price   Intrinsic Value 
                 
$0.25 - $0.28   1,727,778    2.831   $0.27       
                    

 

Stock Warrants:

 

The following table provides the activity in warrants to purchase shares of Common Stock for the respective periods:

 

               
       Weighted     
       Average   Aggregate 
   Total Warrants   Exercise Price   Intrinsic Value 
             
Balance at December 31, 2021   138,191,666   $0.29   $3,824,750 
Granted   5,242,424    0.33    —   
Balance at March 31, 2022   143,434,090   $0.29   $1,147,100 
Granted   500,000    0.33      
Expired – cancelled   (2,045,000)   0.00      
Balance at June 30, 2022   141,889,090   $0.29   $204,000 
Granted   1,000,000    0.33    —   
Exercised   (1,333,333)   0.08      
Expired – cancelled   (1,500,000)   0.00    —   
Balance at September 30, 2022   140,055,757   $0.29   $150,667 
Balance at December 31, 2022   139,557,757   $0.29   $1,147,100 
Granted               —   
Cancelled               —   
Balance at March 31, 2023   139,557,757   $0.29   $1,147,100 
Granted                
Expired – cancelled   (7,342,000)          
Balance at June 30, 2023   132,215,757   $0.29   $150,667 
Granted               —   
Exercised               —   
Expired – cancelled   (5,920,000)   0.00    —   
Balance at September 30, 2023   126,295,757   $0.30   $150,667 

 

 

Warrants exercisable and outstanding at September 30, 2023 are as follows:

 

                      
        Weighted Average         
        Remaining         
Range of   Number   Contractual   Weighted Average   Aggregate 
Exercise Prices   Outstanding   Life (Years)   Exercise Price   Intrinsic Value 
                  
 $0.01 - $0.50    126,295,757    2.65    0.30   $150,667 
 $0.51 - $1.00          —               
      126,295,757             $150,667 

 

18 
BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

 

 

 

NOTE 11 – SUBSEQUENT EVENTS

 

 

On November 9th, 2023 the Company and its Interim CEO agreed to accrue a total of 50% of the monthly engagement fee of $16,666 for the remaining portion of the agreement which ends December 15, 2023. The full amount of the accrual will be paid to Mr. Richmond upon the Company receiving funding for the 2024 operations. The Company further agreed to pay Mr. Richmond a total of 20% interest per annum for a period of six months while the Company awaits funding for operations.

 

On or about September 15, 2023 the Company filed suit in the state of Florida for the ongoing lawsuit against UCP with regards to the completion of the equipment ordered in 2021. As of this filing the matter remains unresolved.

 

 

 

 

 

19 
 

 

ITEM 2.MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

This overview provides a high-level discussion of our operating results and some of the trends that affect our business. We believe that an understanding of these trends is important to understand our financial results for the six months ended June 30, 2023 and 2022, respectively. This summary is not intended to be exhaustive, nor is it intended to be a substitute for the detailed discussion and analysis provided elsewhere in this report, and our audited consolidated financial statements and accompanying notes included in the Annual Report in Form-10-K for the period ended December 31, 2022 and filed with the SEC on May 16, 2023.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). These forward-looking statements are based on our management’s beliefs, assumptions, and expectations and on information currently available to our management. Generally, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “predicts,” “potential” and similar expressions intended to identify forward-looking statements, which generally are not historical in nature. All statements that address operating or financial performance, events, or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing for our planned manufacturing expansion and/or new lease for manufacturing and headquarters space, the benefits of our products, customer leads, product sales, financings, or the commercial viability of, and prospects for, our business model. We may not actually achieve the plans, projections or expectations disclosed in forward-looking statements, and actual results, developments or events (including, without limitation, those related to our planned manufacturing relocation and expansion and our sales and marketing initiatives) could differ materially from those disclosed in the forward-looking statements. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. We do not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by federal securities laws and the rules of the Securities and Exchange Commission (the “SEC”). We may not actually achieve the plans, projections or expectations disclosed in our forward-looking statements, and actual results, developments or events could differ materially and adversely from those disclosed in the forward-looking statements. Forward-looking statements are subject to a number of significant risks and uncertainties, including without limitation those described from time to time in our reports filed with the SEC.

 

The following discussion and analysis of our financial condition and results of operations should be read together with our unaudited interim condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q as well as the risk factors and other disclosures contained in our Annual Report on Form 10-K for the period ended December 31, 2022.

 

Basanite, Inc., and its wholly owned subsidiaries are referred to in this discussion as the “Company”, “we”, “our”, or “us”. “Common Stock” refers to the Common Stock of the Company.

 

Overview

 

On May 30, 2006, Basanite, Inc. was formed as a Nevada corporation. Through our wholly owned subsidiary, Basanite Industries, LLC, a Delaware limited liability company (“BI”), we manufacture a range of “green” (environmentally friendly), sustainable, non-corrosive, lightweight, composite products used in concrete reinforcement by the construction industry. Our core product is BasaFlex™, a basalt fiber reinforced polymer reinforcing bar (“rebar”) which we believe is a stronger, lighter, sustainable, non-conductive and corrosion-proof alternative to traditional steel.

 

Our two other main product lines are BasaMix™, which are fine denier basalt fibers available in various chopped sizes, and BasaMesh™, a line of Basalt Geogrid Mesh Rolls, intended to replace welded wire mesh (made of steel) and other fiber reinforced polymer grids and mesh.

 

BasaMix™ is designed to help absorb the stresses associated with early-aged plastic shrinkage and settlement cracking in concrete, as well as providing an increased toughness for enhanced reinforcement in Slab on Grade (SOG) and precast elements. BasaMix™ also serves in a “system approach” for optimum performance of a concrete element when used in conjunction with our BasaFlex™ rebar.

 

BasaMesh™ is designed for secondary and temperature shrinkage reinforcement. BasaMesh™ can also work in conjunction with the BasaFlex™ rebar or BasaMix™ for a total reinforcement program.

 

Each of our products is specifically designed to extend the lifecycle of concrete products by eliminating “concrete spalling.” Spalling results from the steel reinforcing materials embedded within the concrete member rusting (contrary to popular belief, concrete is porous, and water can permeate into concrete). Rusting leads to the steel expanding and eventually causing the surrounding concrete to delaminate, crack, or even break off, resulting in potential structural failure. We believe that each of our products addresses this important need along with other key requirements in today’s construction market.

 

 

20 
 

 

 

We believe that the following attributes of BasaFlex™ provide it with a competitive advantage in the marketplace:

 

BasaFlex™ never corrodes: steel reinforcement products rust, leading to spalling and significant repair costs down the road;

 

BasaFlex™ is sustainable: BasaFlex™ is made from Basalt rock, the most abundant rock found on Earth’s surface, and offers a longer product lifecycle than traditional steel (the lack of corrosion allows the life span of concrete products reinforced with BasaFlex to be significantly longer);

 

BasaFlex™ is “green”: From mining, through production, to installation at the building site, BasaFlex™ has an exceptionally low carbon footprint when compared with that of steel or with carbon fiber or glass fiber reinforced polymer rebar products; and

 

BasaFlex™ has a lower in-place cost: the physical nature of our products relative to steel result in a lower net cost to the contractor once installed, such as: BasaFlex™ is one-quarter of the weight of equivalent sized steel, meaning 4 times the quantity of material can be delivered by the same truck (or container); all Basanite products can be loaded/unloaded and moved around the jobsite by hand – no expensive handling equipment is needed; less concrete is required as BasaFlex™ does not require the extra concrete cover needed when using steel; and Basanite products are safer and easier to use. We believe all these factors materially reduce the net in-place cost of concrete reinforcement.

 

 

During the past year, we have designed, developed, and prototyped a next generation Pultrusion manufacturing system we call BasaMax™. This new system has been designed in two versions, a quad-line system (for smaller bar sizes) and a dual-line system (for larger bar sizes), which not only have double the manufacturing capacity of the current machines, but they also run faster and they fit it the same manufacturing floorspace. We currently have five of these new BasaMax pultrusion machines on order: three quad-line machines and two dual-line machines. We expect to have these new machines in place during the third quarter of 2023. With the introduction of this new equipment and the establishment of our planned two-shift operations, our maximum manufacturing capacity for BasaFlex™ rebar will increase to approximately 128,000 linear feet per working day (on a two-shift basis).

 

Importantly, BI’s own fully equipped Test Lab is utilized to evaluate, validate, and verify each raw material and each batch of completed BasaFlex™ product, ensuring our finished goods meet the required specifications and performance attributes. We are also developing a new process specifically for manufacturing BasaFlex™ shapes (hoops; angles and stirrups) which we call BasaLinks™, which includes developing a next generation pultrusion system as part of this process. We expect our first BasaLinks system to be in place and operational during the second quarter of 2024.

 

We believe that macroeconomic factors are pressuring the construction industry to consider the use of alternative reinforcement materials for the following reasons:

 

the increasing need for global infrastructure repair;

 

recent design trends towards increasing the lifespan of projects and materials;

 

the global interest in promoting the use of sustainable products;

 

increasing consideration of both the long-term costs and environmental impacts of material selections.

 

more recently, due to rising steel prices, an increasing level of price equivalence between steel rebar and our BFRP rebar.

 

We believe we are well positioned to benefit from this renewed focus, particularly in light of the interest of the U.S. government in funding infrastructure improvements and events such as the collapse of a residential building in Surfside, Florida. 

 

Inflation & Interest Rate Sensitivity

 

In the past two fiscal years, inflation has not had a significant impact on our business. However, during the second half of 2021 and into 2022, the U.S. economy has entered into a period of increasing inflation. Should inflation persist or increase, interest rates may continue to rise, and inflation overall could have a significant effect on the economy in general and the construction industry in particular, as well as create volatility in the capital markets. For example, inflation and increased interests could affect the prices of raw materials we use, demand for our products, our ability to attract and retain skilled labor and our ability to obtain financing. We are carefully watching chemical prices, which are following oil and gas prices, as a core component of BasaFlex™ is the chemical resin mix. Prices have risen, but we have been able to raise our own prices to support our margins, largely as the result of the increase in steel prices. We believe we have actually benefitted from the rapid rise in steel prices over the past 6 to 9 months as well as the reduced availability of steel rebar, both of which changes have opened opportunities to more readily introduce our products into the marketplace. As of the date of this report, BasaFlex™ has become directly competitive with steel on price alone, and it is relatively available, whereas steel has been impacted by raw material supply chain constraints. We will seek to continue to take advantage of these opportunities while high steel prices and restricted supply are prevalent. Supply Chain

  

Supply Chain

In the past year, supply chain shortages or delays have had an immaterial impact on our operations. Our raw material suppliers have maintained a consistent flow of goods which we receive monthly. Domestic suppliers have increased their in-stock flows to maintain adequate levels with our manufacturing needs. However, we might experience supply chain challenges in the future, which could harm our business and our results of operations.

 

War in Ukraine

The recent war in Ukraine has led the world to issue sanctions on the government of Russia. This has shut down our ability to procure basalt fiber material from our secondary supplier, UWF/Kamenny Vek. However, our primary supplier, Mafic, is U.S. based, and has ample capacity to support our current and anticipated future needs with 100% domestic source of raw materials. We have also recently increased the levels of our safety stock of raw materials as an additional cushion. Nonetheless, we are currently qualifying alternate material from other suppliers to preserve our options in case of further disruptions.

 

Government Approvals and Specifying of our Products

We continue to pursue additional product and facility qualifications and approvals, and these qualifications and approvals are critical to the market acceptance of our products. We are currently testing products at two independent laboratories in the pursuit of ICC-ES certification and a FDOT production facility approval which was awarded in July 2023. We are already selling to FDOT projects on an individual basis through exemptions or specs. The FDOT approval will allow us to bid on any project approved for basalt fiber reinforced polymer products. Although we have obtained these additional approvals, our opportunities to bid on certain projects will be limited due to the inability to produce products until 2024.

 

21 
 

 

Known Factors, Trends and Risks Impacting Our Business

 

Search for New Facilities and Manufacturing Expansion

 

Our business plan calls for scaling the manufacturing capability to enable the potential for increased revenues and cash flow positive operations, and ultimately to profitability, in as short a timeframe as possible. As discussed above, we are currently searching for a new headquarters and manufacturing facility. Once and assuming this new facility is established and fully operational, we plan to open additional facilities around the country based on demand, each designed to service a circular area roughly 1,000 miles in diameter, with the plant at the center.

 

However, our manufacturing expansion plans have been hindered by several factors: the COVID-19 pandemic, our slower than expected rate of fundraising and our slower than expected ramp-up in sales. This last item has been caused by multiple factors, including:

 

Customer requirements for multiple additional product and facility certifications, in particular:

 

oInternational Code Council (or ICC) Evaluation Service (known as “ICC-ES”) Certification to AC 454. ICC-ES is an industry leader in performing technical evaluations of building products, materials and systems for code compliance. Basanite’s Product ICC-ES certification testing and facility audit were both successfully completed in the third quarter of 2022, and we received ICC-ES approval in September 2022;
o Approval by the Florida Department of Transportation (“FDOT”). We have previously received FDOT with facility approval (FRP22), and our product approval is pending successful completion of FDOT’s product certification testing program, which is nearing the end of the long-duration product testing currently underway at the University of Sherbrooke, Canada (9 month program). This FDOT testing was completed during the third quarter of 2023 with final approval the third quarter of 2023 as well;

 

oThe lack of an ASTM (formerly known as the American Society for Testing and Materials) product standard specifically for basalt fiber. A member of our board of directors, Fred Tingberg, who was appointed as our Chief Technology Officer in June 2022, was appointed to the ASTM committee to review this and helped bring the process to conclusion. The new ASTM Specification for Basalt Fiber, D-8448-22 was issued in September 2022;
oThe lack of an ASTM product standard covering basalt fiber rebar (this process is underway). A new ASTM Specification for High-Performance Rebar is expected to be issued in the first quarter of 2024;

 

Customer concerns about our current manufacturing capacity, which have precluded us from bidding or winning several larger potential orders;

 

The Surfside Condo disaster, which has resulted in some local engineers being cautious around new product introductions. We believe, however, that we will be able to make a strong case that BasaFlex™ (which is corrosion proof) can remedy the structural failures (such as what occurred in Surfside) associated with steel reinforcement corrosion;

 

Our new manufacturing equipment mentioned above is has not been completed by the manufacturer and was expected to be delivered and the installation and calibration process to commence during the fourth quarter of 2022 or early in 2023, assuming we are able to secure a new manufacturing facility. The equipment is expected to become fully operational shortly thereafter should both parties come to a resolution. We believe the achievement of this would simultaneously resolve questions about our manufacturing capacity and will materially improve our ability to generate larger sales order.

 

 

22 
 

 

Supply Chain Issues

 

In the past year, supply chain shortages or delays have had an immaterial impact on our operations. However, on October 31, 2022, we were notified by Mafic USA, LLC (our primary U.S. supplier of basalt fiber, which is the key component in our products) that they would be ceasing manufacturing operations in order to engage in a possible restructuring. As discussed below, we have a second supplier of basalt fiber located in Russia, but at the present time, we require a U.S. supplier of basalt fiber, and the absence of such a supplier, if it continues, would have a material adverse effect on our ability to conduct operations. We have been diligently researching other domestic sources of basalt fiber, and we continue to work with a domestic broker of international basalt fiber sourcing.

 

War in Ukraine

 

The recent war in Ukraine has led the world to issue sanctions on the government of Russia. This directly resulted in a significant price increase of basalt fiber material from our fiber supplier in Russia, Kamenny Vek. Of note, as described above under “Supply Chain” Kamenny Vek is presently our only operating suppler for basalt fiber, and this dependence is a risk factor for us until we can identify alternate suppliers. We have been fortunate as we have been able to raise our finished goods pricing to compensate without any notable affect to customer demand. We have also recently increased the levels of our safety stock of raw materials as an additional cushion. Nonetheless, we are currently qualifying alternate fiber and other materials from other global suppliers to preserve our options in case of further disruptions. We might experience further supply chain challenges in the future because of the war in Ukraine, which could harm our business and our results of operations.

 

Government Approvals and Specifying of our Products

 

We continue to pursue additional product and facility qualifications and approvals, and these qualifications and approvals are critical to the market acceptance of our products. As previously noted, we are currently testing products at an independent university laboratory (University of Sherbrooke) in the pursuit of FDOT certification. Formal FDOT approval was granted the second quarter of 2023.

 

Inflation & Interest Rate Sensitivity

 

In the past two fiscal years, inflation has not had a significant impact on our business. However, during the second half of 2021 and into 2022, the U.S. economy has entered into a period of increasing inflation. Should inflation persist or increase, interest rates may continue to rise, and inflation overall could have a significant effect on the economy in general and the construction industry in particular, as well as create volatility in the capital markets. For example, inflation and increased interests could affect the prices of raw materials we use, demand for our products, our ability to attract and retain skilled labor and our ability to obtain financing. We are carefully watching chemical prices, which are following oil and gas prices, as a core component of BasaFlex™ is the chemical resin mix. Prices have risen, but we have been able to raise our own prices to support our margins, largely as the result of the increase in steel prices. We believe we have benefitted from the rapid rise in steel prices over the past several fiscal quarters as well as the reduced availability of steel rebar, both of which changes have opened opportunities to more readily introduce our products into the marketplace. As of the date of this report, BasaFlex™ has become competitive with steel on price alone, and it is relatively available, whereas steel has been impacted by raw material supply chain constraints. We will continue to seek opportunities to take advantage of high steel prices and restricted supply while these issues are prevalent.

 

 

23 
 

 

Impact of COVID-19

 

The pandemic caused by the novel coronavirus (known as “COVID-19”) and governmental responses and efforts to curb the spread of the pandemic has caused great disruption to the U.S. national and international economies. We have been adversely impacted by COVID-19 in that we have been required to temporarily suspend operations during 2020 due to necessary quarantines, and the impact of COVID-19 on the construction industry we service has been significant. Government mandated shutdowns and other measures held less of an impact on our business during 2021, although we did have personnel absent for periods during the year due to COVID-19. During the first quarter of 2022, while certain of our personnel did contract COVID-19, overall COVID-19 did not have a material impact on our business, in part because we were operating with reduced personnel and personnel could work remotely in certain cases.

 

The continued prevalence of COVID-19 or outbreaks of new variants thereof could disrupt our supply chain, as well as our own operations due to absenteeism by infected or ill members of management or other employees, or absenteeism by members of management and other employees who elect not to come to work due to illness affecting others in our office or plant, or due to additional necessary quarantines. This could be particularly true as we seek to scale operations during 2022 and hire additional personnel. COVID-19 could also impact members of our Board of Directors as well as key providers of services to us, which could adversely impact the management of our affairs. Additionally, as the COVID-19 pandemic continues to develop, we may be required to continue to spend time and resources in monitoring and adhering to government regulations that impact both our company and our customers and potential customers as necessary, which could also adversely impact our business and results of operations. We continue to monitor our operations and applicable government recommendations and requirements.

 

24 
 

 

Results of Operations for the Three Months Ended September 30, 2023, and 2022

 

Revenue: We had revenue of $49,140 from sales of finished goods for the three months ended September 30, 2023, a decrease of $186,439 compared to $235,579 in the prior year. While the decrease in revenue in the year over year periods was relatively significant due to our increasing sales success (across all product lines) in 2022, overall revenues continue to be minimal, largely due to our capacity ceasing in the third quarter of 2022 and limited working capital. We continued our efforts to increase our sales during the period and subsequently in 2024.

 

Cost of goods sold: Cost of goods sold was $53,640 for the three months ended September 30, 2023, a decrease of $333,981 compared to cost of goods sold of $387,621 during the prior year. The cost of goods sold reflects the fixed overhead costs absorbed by manufacturing, at low sales volumes this results in negative margins.

 

Our gross profit during the three months ended September 30, 2023, was a loss of $4,500 compared to a net gain of $150,442 during the prior period. This change is due to a need for outside production and higher overhead with limited staff. We expect our gross profit to increase as fixed overhead costs are absorbed over a greater volume of sales.

 

Sales, general, and administrative: Sales, general, and administrative expenses were $332,560 during the three months ended September 30, 2023, a decrease of $262,750 compared to $595,310 during the prior year. For the current quarter, sales, general, and administrative costs consisted primarily of professional fees of $52,003; payroll and related costs of $61,291, not including stock-based compensation of $32,939; consulting fees of $59,615.

 

Results of Operations for the Nine Months Ended September 30, 2023, and 2022

 

Revenue: The Company had revenue of $317,664 from sales of finished goods for the nine months ended September 30, 2023, compared to $781,918 in the prior year. While the decrease in revenue in the year over year periods was relatively significant due to our production ceasing at year end in 2022 and sales success (across all product lines) in the earlier quarters of 2022, overall revenues continue to be small, largely due to our capacity constraints and limited working capital.

 

Cost of goods sold: Cost of goods sold was $167,233 for the nine months ended September 30, 2023, a decrease of $1,417,362 compared to cost of goods sold of $1,584,595 during the prior year. The cost of goods sold reflects the fixed overhead costs absorbed by manufacturing, at low sales volumes this results in negative margins.

 

Our gross profit during the nine months ended September 30, 2023, was a gain of $150,432 compared to a loss of $802,677 during the prior period. We expect our gross profit to increase as fixed overhead costs are absorbed over a greater volume of sales.

 

Sales, general, and administrative:

 

Sales, general, and administrative expenses were $1,302,699 during the nine months ended September 30, 2023, a decrease of $1,375,706 compared to $2,678,405 during the prior period. For the current nine-month period, sales, general, and administrative costs consisted primarily of payroll and related costs of $244,356, not including stock-based compensation of $97,205; professional fees of $215,252; consulting fees of $229,615.

 

25 
 

 

 

Liquidity and Capital Resources

 

Since inception, we have incurred net operating losses and negative cash flow. As of September 30, 2023, we had an accumulated deficit of $54,592,600. We have incurred general and administrative expenses associated with our product development and compliance while concurrently setting up our manufacturing facility, beginning operations, and developing our business plan. We also continue to incur legal fees arising from ongoing activities due to fundraising, ongoing public company costs and dispute resolution expenses. We expect operating losses to continue in the short term, and we require additional financing for securing and outfitting our proposed new headquarters and manufacturing space as well as ultimately expanding our manufacturing capability and generally scaling our business until we can generate sufficient revenues to achieve positive cash flow. These conditions raise substantial doubt about our ability to continue as a going concern.

 

We have historically satisfied our working capital requirements through the sale of restricted Common Stock and the issuance of warrants and promissory notes. We will continue our fundraising efforts until we have obtained positive cash flow to cover our expenses. No assurances can be given that we will be successful in raising capital at all or on terms acceptable to us, or at all, and no assurances can be given that even if we raise capital that we will be able to generate sufficient revenue to become cash flow positive.

 

On September 27, 2022, the Company furloughed the majority of the staff to reduce costs during a period of reduced production. We anticipate re-staffing as soon as we are in the new facility with the new equipment. In addition, due to our cash flow and liquidity challenges, we have received demand letters from a number of vendors to our company seeking payment of past due amounts to such vendors. As of the date of this report, such demands have not become formal litigations or other proceedings against our company, but they may become litigations against us in the future.

 

Notwithstanding proceeds from the sale of our securities, recent related party equipment lease transaction and warrant and option exercises in 2023 and 2022, our current working capital is extremely limited, and our projected sales revenue (together with our limited working capital) is presently insufficient to maintain our current operations. In order to establish and grow our manufacturing and sales and marketing operations and reach the level of revenue sufficient to provide positive cash flow, we require significant funding of both our expansion plans (which includes the finalization of our current manufacturing expansion plans and potential investments in other manufacturing facilities, as well as increased headcount necessary to operate our manufacturing at planned capacity). This will cover our significant operating deficit while we seek to establish and scale our manufacturing capability, secure orders from known potential customers, and introduce our products to new customers. We will attempt to raise this capital through third party financing, including potential private or public offerings of our securities (including a potential underwritten offering and listing of our Common Stock on a national securities exchange) as well as bridge or other loan arrangements. However, there is a material risk that we will be unable to secure the required capital (whether through an underwritten financing and/or uplisting to a national exchange or otherwise) at all or that the terms of such required financing may be available or acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. If we are unable to secure funding when needed, our results from operations may suffer, and our business may fail.

As of September 30, 2023, we had cash of $115,273 compared to $30,340 as of December 31, 2022.

 

26 
 

Cash Flows

 

Net cash used in operating activities amounted to 2,147,896 and $907,494 for the nine months ended September 30, 2023, and 2022, respectively. The increase in net cash used in operating activities was primarily a result of a decrease in subscription liability in the amount of $1,775,000.

 

During the nine months ended September 30, 2023, we used $0 cash for investing activities compared to $742,832 used in the same period in the prior fiscal year. The Company has elected to refrain from this expense while it adheres to a restart strategy within the current period, however, the Company will elect to expend funds in the closing of fundraising activities in the remaining quarter of 2023. During the nine months ended September 30, 2023, we had $410,000 net cash provided by proceeds from notes payable, and repayments of notes payable of $25,000.

 

Our cash on hand as of September 30, 2023 or as of the date of this report will not be sufficient to fund our current working capital requirements to the point where we are generating positive cash flow. We have recently entered into several convertible promissory notes and other loan transactions to help fund operations and will require substantial additional working capital in the short term. We continue working towards securing more working capital with a preference towards debt which may be convertible to equity. However, there is no assurance that we will be successful in our efforts or, if we are, that the terms will be beneficial to our shareholders.

 

We do not believe that our cash on hand as of September 30, 2023, will be sufficient to fund our current working capital requirements to the point where we are generating positive cash flow. We have recently entered into several convertible promissory notes to help fund operations and will require additional working capital in the short term. We continue working towards securing more working capital with a preference towards debt which may be convertible to equity. However, there is no assurance that we will be successful in our efforts or, if we are, that the terms will be beneficial to our shareholders.

 

Critical Accounting Estimates

 

The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Please see note 2 to the condensed financial statements included in this report.

 

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

ITEM 4.CONTROLS AND PROCEDURES

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure.

 

Our management, under the supervision and with the participation of our then serving Interim Chief Executive Officer, our Interim Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act) through September 30, 2023.

 

We are committed to maintaining a strong internal control environment and implementing measures designed to help ensure that the material weaknesses described above are remediated as soon as possible. We believe we will have the opportunity to remediate these weaknesses when adequate funding is secured. We will consider the material weaknesses remediated after the applicable controls operate for a sufficient period of time, and management has concluded, through testing, that the controls are operating effectively.

 

Because of its inherent limitations, however, readers are cautioned that internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.

 

Changes in Internal Control over Financial Reporting

 

No change in our system of internal control over financial reporting occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

27 
 

PART II. – OTHER INFORMATION

 

ITEM 1.LEGAL PROCEEDINGS

 

From time to time, we may become involved in legal proceedings that, individually or in the aggregate, could have a material adverse effect on our business, financial condition, cash flows, or results of operations.

As of the date of this report, the Company has filed a lawsuit in the state of South Carolina against Upstate Custom Products, LLC. The lawsuit is based on the contract entered by both parties on August 2021 in relation to the manufacturing of the protrusion machines exclusively manufactured by Upstate Custom Products. LLC. As of this filing the lawsuit and claim for relief is ongoing  .

 

On or about October 2023, the Company was served notice of a pending matter of litigation with GS Capital Partners of New York regarding the liquidated damages fees from the 2021 PIPE investment. As of this filing the matter remains unresolved.

Due to our cash flow and liquidity challenges, we have received demand letters from a number of vendors to our company seeking payment of past due amounts to such vendors. As of the date of this report, such demands have not become formal litigations or other proceedings against our company, but they may become litigations against us in the future.

 

Except as set forth above, as of the date of this report, we are not aware of any proceedings pending against our company.

 

ITEM 1A.RISK FACTORS

 

Not required for smaller reporting companies.

 

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.MINE SAFETY DISCLOSURE

 

Not applicable.

 

ITEM 5.OTHER INFORMATION

 

None.

 

ITEM 6.EXHIBITS
        Incorporation by Reference    
Exhibit Number   Description   Form   Exhibit  
Date
  Filed/Furnished Herewith
                     
31.1*   Certification of Principal Executive Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002               X
31.2*   Certification of Principal Financial Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002               X
32.1+   Certification of Principal Executive Officer pursuant to 18 U.S. C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002               XX
32.2+   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002               XX
101.INS*   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)                X
101.SCH*   XBRL Taxonomy Extension Schema Document.                X
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document                X
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document                X
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document                X
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document                X
104*   Cover Page Interactive Date File (embedded with the Inline XBRL document)                X

 

 

 

28 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 20, 2023

 

  Basanite, Inc.
   
   By: /s/ Thomas Richmond
    Thomas Richmond
Interim Chief Financial Officer

   
   By: /s/ Jackie Placeres
    Jackie Placeres
Interim Chief Financial Officer

 

 

 

 

29 
 

EXHIBIT 31.1

 

OFFICER’S CERTIFICATE

 

PURSUANT TO RULE 13a-14(a)/15d-14(a)

 

I, Thomas Richmond, Interim Chief Financial Officer, certify that:

 

1.I have reviewed this Form 10-Q for the quarter ended September 30, 2023, of Basanite, Inc.;

 

2.          Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.          Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.          I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15 (e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant issuer and have:

 

(a)          Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)         Designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)          Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)         Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.          I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)         All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 20, 2023

 

By: /s/ Thomas Richmond
       
  Name: Thomas Richmond
  Title: Interim Chief Financial Officer

 

 

 

EXHIBIT 31.2

 

OFFICER’S CERTIFICATE

 

PURSUANT TO RULE 13a-14(a)/15d-14(a)

 

I, Jackie Placeres, Interim Chief Financial Officer, certify that:

 

1.I have reviewed this Form 10-Q for the quarter ended September 30, 2023, of Basanite, Inc.;

 

2.          Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.          Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.          I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15 (e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant issuer and have:

 

(a)          Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)         Designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)          Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)         Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.          I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)         All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 20, 2023

 

By: /s/ Jackie Placeres
       
  Name: Jackie Placeres
  Title: Interim Chief Financial Officer

 

 

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

 

18 U.S.C. SECTION 1350

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Basanite, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023 as filed with the United States Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

 

Date: November 20, 2023 By: /s/ Thomas Richmond
       
  Name: Thomas Richmond
  Title: Interim Chief Executive Officer, President
   

 

 

A signed original of this written statement required by Section 906, or other document authentications, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Basanite, Inc. and will be retained by Basanite, Inc. and furnished to the United States Securities and Exchange Commission or its staff upon request.

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

 

18 U.S.C. SECTION 1350

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Basanite, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the United States Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: November 20, 2023 By: /s/ Jackie Placeres
       
  Name: Jackie Plaeceres
  Title: Interim Chief Financial Officer
   

 

 

A signed original of this written statement required by Section 906, or other document authentications, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Basanite, Inc. and will be retained by Basanite, Inc. and furnished to the United States Securities and Exchange Commission or its staff upon request.

 

 

v3.23.3
Cover - shares
9 Months Ended
Sep. 30, 2023
Nov. 15, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 000-53574  
Entity Registrant Name Basanite, Inc.  
Entity Central Index Key 0001448705  
Entity Tax Identification Number 20-4959207  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 2660 NW 15th Court  
Entity Address, Address Line Two Unit 108  
Entity Address, City or Town Pompano Beach  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33069  
City Area Code (954)  
Local Phone Number 532-4653  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   259,156,796
v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2023
Dec. 31, 2022
CURRENT ASSETS    
Cash $ 115,273 $ 30,340
Accounts receivable, net 39,455 67,960
Prepaid expenses 85,481 137,370
TOTAL CURRENT ASSETS 240,209 235,670
Lease right-of-use asset 80,724 153,270
Fixed assets, net 434,233 530,238
TOTAL NON CURRENT ASSETS 514,957 683,508
TOTAL ASSETS 755,166 919,178
CURRENT LIABILITIES    
Accounts payable 1,764,146 1,713,045
Accrued expenses 878,066 438,870
Accrued legal liability 165,000 165,000
Subscription liability 1,300,000
Notes payable 270,000 304,243
Due to shareholders 475,000  
Notes payable - related party 1,575,000 605,000
Notes payable - convertible - related party, net 2,144,357 2,144,357
Lease liability – operating, current portion 80,724 93,186
TOTAL CURRENT LIABILITIES 7,352,293 7,268,701
Lease liability – operating, net of current portion 56,915
TOTAL LIABILITIES 7,352,293 7,325,616
STOCKHOLDERS’ (DEFICIT) EQUITY    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding
Common stock, $0.001 par value, 1,000,000,000 shares authorized, 253,217,402 and 248,840,144 shares issued and outstanding, respectively 259,157 253,218
Additional paid-in capital 48,824,620 47,433,354
Accumulated deficit (55,680,904) (54,093,010)
TOTAL STOCKHOLDERS' (DEFICIT) EQUITY (6,597,127) (6,406,438)
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY $ 755,166 $ 919,178
v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 1,000,000,000 1,000,000,000
Common stock, shares issued 253,217,402 248,840,144
Common stock, shares outstanding 253,217,402 248,840,144
v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue        
Products sales - rebar $ 49,140 $ 235,579 $ 317,664 $ 781,918
Total cost of goods sold 53,640 387,621 167,223 1,584,595
Gross (loss) (4,500) (152,042) 150,441 (802,677)
OPERATING EXPENSES        
Sales, general, and administrative 332,560 595,310 1,302,699 2,678,405
Total operating expenses 332,560 595,310 1,302,699 2,678,405
NET LOSS FROM OPERATIONS (337,060) (747,352) (1,152,258) (3,481,082)
OTHER INCOME (EXPENSE)        
Liquidated damages – loan commitment (426,759)
Miscellaneous income 30 30
Loss on extinguishment of debt (6,743,015)
Gain on loan forgiveness 170,096 170,096
Interest expense (162,529) (84,467) (435,636) (388,701)
Total other income (expense) (162,529) 85,659 (435,636) (645,334)
NET LOSS $ (499,589) $ (661,693) $ (1,587,894) $ (4,126,416)
Net loss per share –        
Basic $ (0.02) $ (0.00) $ (0.01) $ (0.02)
Diluted $ (0.02) $ (0.00) $ (0.01) $ (0.02)
Weighted average number of shares outstanding –        
Basic 259,156,796 253,187,772 259,156,796 251,736,069
Diluted 259,156,796 253,187,772 259,156,796 251,736,069
v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 248,842 $ 46,054,126 $ (46,121,210) $ 181,758
Beginning balance, shares at Dec. 31, 2021 248,840,144      
Stock issued for cash, net of costs of $50,409 $ 2,121 647,470 649,591
Stock issued for cash, net of costs, shares 2,121,212      
Shares issued for exercise of warrants $ 500 124,500 125,000
Shares issued for exercise of warrants, shares 500,000      
Stock issued to service provider $ 300 57,600 57,900
Stock issued to service provider, shares 300,000      
Warrants issued to management 169,565 169,565
Net loss (1,520,661) (1,520,661)
Ending balance, value at Mar. 31, 2022 $ 251,763 47,053,261 (47,641,871) (336,847)
Ending balance, shares at Mar. 31, 2022 251,761,356      
Shares issued to related party for services $ 122 18,162 18,284
Shares issued to related party for services, shares 122,713      
Vesting of warrants issued to management 41,706 41,706
Warrants issued to Related Party for services provided 64,264 64,264
Net loss (1,944,062) (1,944,062)
Ending balance, value at Jun. 30, 2022 $ 251,885 47,177,393 (49,585,933) (2,156,655)
Ending balance, shares at Jun. 30, 2022 251,884,069      
Shares issued for exercise of warrants $ 1,333 98,667 100,000
Shares issued for exercise of warrants, shares 1,333,333      
Warrants issued to service provider 157,294 157,294
Net loss (661,693) (661,693)
Ending balance, value at Sep. 30, 2022 $ 253,218 47,433,354 (50,247,626) (2,561,054)
Ending balance, shares at Sep. 30, 2022 253,217,402      
Beginning balance, value at Dec. 31, 2022 $ 253,218 47,433,354 (54,093,010) (6,406,438)
Beginning balance, shares at Dec. 31, 2022 253,217,402      
Warrants exercised for cash
Stock-based compensation 64,266 64,266
Net loss (468,454) (468,454)
Ending balance, value at Mar. 31, 2023 $ 253,218 47,497,620 (54,561,464) (6,810,626)
Ending balance, shares at Mar. 31, 2023 253,217,402      
Stock issued for cash $ 3,939 1,296,061 1,300,000
Stock issued for cash, shares 3,939,394      
Net loss (619,851) (619,851)
Ending balance, value at Jun. 30, 2023 $ 257,157 48,793,681 (55,181,315) (6,130,477)
Ending balance, shares at Jun. 30, 2023 257,156,796      
Stock issued to management $ 2,000 30,939 32,939
Stock issued to management, shares 2,000,000      
Net loss 499,589 499,589
Ending balance, value at Sep. 30, 2023 $ 259,157 $ 48,824,620 $ (55,680,904) $ (6,597,127)
Ending balance, shares at Sep. 30, 2023 259,156,796      
v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) (Parenthetical)
3 Months Ended
Mar. 31, 2022
USD ($)
Statement of Stockholders' Equity [Abstract]  
Net of cost $ 50,409
v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (1,587,894) $ (4,126,416)
Adjustments to reconcile net loss to net cash used in operating activities:    
Lease right-of-use asset amortization, operating lease 72,546 220,933
Lease right-of-use asset amortization, financing lease (1,725)
Lease right-of-use asset amortization, financing lease, related party (705)
Depreciation and amortization 96,005 100,670
Loan forgiveness (170,096)
Stock-based compensation 97,205 509,013
Changes in operating assets and liabilities:    
Prepaid expenses 51,889 (43,132)
Inventory 431,098
Accounts receivable (28,505) (57,917)
Deposits and other current assets 12,117
Accounts payable and accrued expenses 517,297 1,159,268
Subscription liability 1,300,000
Lease liability, operating lease (39,367) (238,595)
Lease liability, financing lease (563)
Lease liability, financing lease – related party (1,444)
Net cash used in operating activities (820,824) (907,494)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of equipment (780,476)
Proceeds from sale of equipment 450,000
Net cash used in investing activities (330,476)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of common stock, net of costs 649,591
Proceeds from exercise of warrants 225,000
Proceeds from notes payable and notes payable related party 970,000 305,000
Repayments of notes payable and notes payable related party (64,234) 20,158
Net cash provided by financing activities 905,757 1,199,749
NET (DECREASE) INCREASE IN CASH 84,233 (38,221)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 30,340 109,514
CASH AND CASH EQUIVALENTS AT END OF PERIOD 115,273 71,293
Supplemental cash flow information:    
Cash paid for income taxes
Cash Paid for interest
Forgiveness of Paycheck Protection Program loan and accrued interest 167,996
Supplemental disclosure of non-cash investing and financing activities:    
Accounts payable paid by financing lease, related party 450,000
Extension of convertible note interest rolled in $ 337,950
v3.23.3
ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN

NOTE 1 – ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN

 

(A) Description of Business

 

Basanite, Inc., a Nevada corporation (the “Company”, “Basanite”, “we”, “us”, “our” or similar terminology), through our wholly owned subsidiary, Basanite Industries, LLC, a Delaware limited liability company (“BI”), manufactures a range of “green” (environmentally friendly), sustainable, non-corrosive, lightweight, composite products used in concrete reinforcement by the construction industry. Our core product is BasaFlex™, a basalt fiber reinforced polymer reinforcing bar (“rebar”) which we believe is a stronger, lighter, sustainable, non-conductive and corrosion-proof alternative to traditional steel.

 

Our two other main product lines are BasaMix™, which are fine denier basalt fibers available in various sizes, and BasaMesh™, a line of Basalt Geogrid Mesh Rolls, intended to replace welded wire mesh (made of steel) and other fiber reinforced polymer (“FRB”) grids and mesh.

 

BasaMix™ is designed to help absorb the stresses associated with early-aged plastic shrinkage and settlement cracking in concrete, as well as providing an increased toughness for enhanced reinforcement in Slab-on-Grade (“SOG”) and precast elements. BasaMix™ also serves in a “system approach” for optimum performance of a concrete element when used in conjunction with our BasaFlex™ rebar.

 

BasaMesh™ is designed for secondary and temperature shrinkage reinforcement. BasaMesh™ can also work in conjunction with the BasaFlex™ rebar or BasaMix™ for a total reinforcement program.

 

Each of our products is specifically designed to extend the lifecycle of concrete products by eliminating “concrete spalling.” Spalling results from the steel reinforcing materials embedded within the concrete member rusting (contrary to popular belief, concrete is porous and water can permeate into concrete). Rusting leads to the steel expanding and eventually causing the surrounding concrete to delaminate, crack, or even break off, resulting in potential structural failure. We believe that each Basanite product addresses this important need along with other key requirements in today’s construction market.

 

Manufacturing

 

We previously leased a fully permitted, 36,900 square foot facility located in Pompano Beach, Florida equipped with five customized, Underwriters Laboratories approved, Pultrusion manufacturing machines for BasaFlex™ production, plus other composite manufacturing equipment. Each Pultrusion machine has up to two linear production lines (we use one or two lines per machine depending on rebar size – giving a maximum capacity of 10 manufacturing lines). To date, BI’s operations team has successfully optimized and scaled the capacity of our manufacturing plant to produce up to 25,000 linear feet of BasaFlex™ rebar per shift, per day, depending on the product mix. BI’s own fully equipped test lab is utilized to evaluate, validate, and verify each product’s performance attributes. Depending on our manufacturing needs in the future, we have and may continue to explore alternative or additional manufacturing or corporate facilities. As of December 31, 2022, we no longer operate nor manufacture in our previous Pompano Beach facility.

 

To satisfy what we perceive the market interest for BasaFlex™ to be, and in particular to address potential large-scale customers like CPPB, we need to significantly accelerate the expansion of our manufacturing capacity. Our current goal is to locate a new manufacturing facility and restart our manufacturing operations and ultimately to reach a plant production capacity exceeding 73,000 linear feet per day per day on a two day shift basis (which would be 3 times our current capacity). To accomplish these goals, we have designed and developed customized pultrusion equipment which offers significantly increased capacity in the same footprint as our current equipment. Our new technology manufacturing system, named BasaMax™, has been specifically designed for the manufacture of BasaFlex™ using our patent pending process. Two versions of this equipment have been designed, and these will not only offer double the capacity of our current equipment (per machine), but also each will run at faster and more efficient rates. A prototype has completed thorough testing in our previous Pompano facility, including initial production runs, and is currently undergoing modifications and upgrades to the final production configuration.

Based on this trial, we are planning a two-phase plant expansion, eventually including a total of 10 of these new machines. Our goal, subject to raising sufficient funding of about 5 million dollars, is to have the first set of five of the new machines installed and be operational by the end of the second quarter of 2024 and to install and have operational five more, along with additional custom manufacturing equipment, by the fourth quarter of 2024 providing sales dictate for the 2025 production year. This would create the opportunity for BI to ultimately reach our production level target for the new facility by the end of the second quarter 2025. 

(B) Liquidity and Management Plans

 

Since inception, the Company has incurred net operating losses and used cash in operations. As of September 30, 2023, and December 31, 2022, respectively, the Company reported:

 

an accumulated deficit of $55,680,904 and $54,093,010.

 

a working capital deficiency of $7,112,084 and $7,033,031; and

 

cash used in operations of $820,824 and $907,494.

 

Losses have principally occurred as a result of the substantial resources required for product research and development, establishment and upgrading of our manufacturing facility and equipment, and for certification, government approval and marketing of the Company’s products; including the general and administrative expenses associated with the organization.

 

While we have generated relatively little revenue to date, revenue from sales of product began to increase during the first half of 2023 (including the quarter ended September 30, 2023), and we continue to receive inquiries and solicit orders from a range of customers for our products, indicating what we believe is a significant level of market interest for BasaFlex™ and BasaMix™ products. We also spent time and resources during the first half of 2023 introducing our products to, and receiving approvals and certifications from, various county and local government agencies to have our products used in such agencies’ construction projects.

 

We have historically satisfied our working capital requirements through the sale of restricted Common Stock of the Company, $0.001 par value per share (the “Common Stock”), and the issuance of warrants to purchase Common Stock and promissory notes. Until we are able to internally generate meaningful revenue and positive cash flow, we will attempt to fund working capital requirements through third party financing, including through potential private or public offerings of our securities as well as bridge or other loan arrangements. However, a number of factors continue to hinder the Company’s ability to attract new capital investment. We cannot provide any assurances that the required capital will be obtained at all, or that the terms of such required capital may be acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. If we are unable to secure funding when needed, our results of operations may suffer, and our business may fail.

 

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties.

 

We have historically satisfied our working capital requirements through the sale of restricted common stock of the Company, $0.001 par value per share (the “Common Stock”), and the issuance of warrants to purchase Common Stock and promissory notes, some of which were or are convertible into shares of Common Stock. Until we are able to internally generate meaningful revenue and positive cash flow, we will attempt to fund working capital requirements through third party financing, including through potential private or public offerings of our securities as well as bridge or other loan arrangements. However, a number of factors continue to hinder the Company’s ability to attract new capital investment. We cannot provide any assurances that the required capital will be obtained at all, or that the terms of such required capital may be acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. If we are unable to secure funding when needed, our results of operations may suffer, and our business may fail.

 

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties.

 

At September 30, 2023, the Company had cash of $115,273 compared to $30,340 at December 31, 2022.

 

v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

(A) Use of Estimates in Financial Statements

 

The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Stock-based compensation and stock awards related to convertible debt instruments are recognized based on the fair value of the awards granted. The fair value of each award or conversion feature is typically estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions, including the fair value of the underlying Common Stock, the expected term of the option, the expected volatility of the price of our Common Stock, risk-free interest rates and the expected dividend yield of our Common Stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.

 

The Company used the Black Scholes valuation model to determine the fair value of the warrants and options issued, using the following key assumptions for the nine months ended September 30, 2022. There were no such valuations during the nine months ended September 30, 2023:

        
   Nine months   Nine months 
   ended   ended 
   September 30,   September 30, 
   2023   2022 
   (Unaudited)     
Expected price volatility  N/A   144.21-145.773% 
Risk-free interest rate  N/A   2.55-4.21 
Expected life in years  N/A   5 
Dividend yield  N/A   N/A 

 

(B) Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of Basanite, Inc. and its wholly owned subsidiaries, Basanite Industries, LLC and Basalt America, LLC. All intercompany balances have been eliminated in consolidation. The Company’s operations are conducted primarily through Basanite Industries, LLC. Basalt America, LLC is currently inactive.

 

(C) Cash

 

The Company considers all highly liquid temporary cash instruments with an original maturity of three months or less to be cash equivalents. The Company places its cash, cash equivalents and restricted cash on deposit with financial institutions in the United States, which are insured by the Federal Deposit Insurance Company “(“FDIC”) up to $250,000. The Company’s credit risk in the event of failure of these financial institutions is represented by the difference between the FDIC limit and the total amounts on deposit. Management monitors the financial institutions' creditworthiness in conjunction with balances on deposit to minimize risk. The Company from time to time may have amounts on deposit in excess of the insured limits.

 

(D) Inventories

 

The Company’s inventories consist of raw materials, work in process and finished goods, both purchased and manufactured. Inventories are stated at lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. Raw materials inventory consists of basalt fiber and other necessary elements to produce BasaFlex™ rebar and our other products. On a quarterly basis, the Company analyzes its inventory levels and records allowances for inventory that has become obsolete and inventory that has a cost basis in excess of the expected net realizable value.

 

The Company’s inventory at September 30, 2023 and December 31, 2022 was (0) zero.

 

(E) Fixed assets

 

Fixed assets consist of the following:

          
   September 30,   December 31, 
   2023   2022 
    (Unaudited)      
Computer equipment  $203,193   $203,193 
Machinery   728,245    728,245 
Leasehold improvements            
Office furniture and equipment            
Land improvements            
Website development            
Construction in process            
    931,438    931,438 
Accumulated depreciation and amortization   (497,205)   (401,200)
   $434,233   $530,238 

 

Depreciation expense for the three and nine months ended September 30, 2023, was $31,962 and $96,005, respectively; depreciation expense for the three months and nine months ended September 30, 2022, was $33,919 and $100,670, respectively.

 

(F) Deposits and other current assets

 

The Company’s deposits and other current assets consist of the deposits made on equipment, security deposits, utility deposits and other receivables. The deposits are reclassified as part of the fixed asset cost when received and placed into service.

 

(G) Loss Per Share

 

The basic loss per share is calculated by dividing the Company’s net loss available to common shareholders by the weighted average number of common shares during the period. The diluted loss per share is calculated by dividing the Company’s net loss by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.

 

The following are potentially dilutive shares not included in the loss per share computation:  

          
   September 30,   December 31, 
   2023   2022 
    (Unaudited)      
Options   1,477,778    1,477,778 
Warrants   126,295,757    139,555,757 
Convertible securities   8,016,068    8,016,068 
Total   149,799,603    149,389,507 

 

(H) Stock-Based Compensation

 

The Company recognizes compensation costs to employees under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation – Stock Compensation. Under FASB ASC Topic 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the grant.

 

(I) Revenue Recognition

 

We recognize revenue when control of the promised goods or services is transferred to the Company’s customers in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. The timing of revenue recognition largely is dependent on shipping terms. Revenue is recorded at the time of shipment for terms designated free on board (“FOB”) shipping point. For sales transactions designated FOB destination, revenue is recorded when the product is delivered to the customer’s delivery site.

 

All revenues recognized are net of trade allowances, cash discounts, and sales returns. Trade allowances are based on the estimated obligations. Adjustments to earnings resulting from revisions to estimates on discounts and returns have been immaterial for each of the reported periods. Shipping and handling amounts billed to a customer as part of a sales transaction are included in revenues, and the related costs are included in cost of goods sold. Shipping and handling are treated as fulfillment activities, rather than promised services, and therefore are not considered separate performance obligations. During the three and nine months ended September 30, 2023, and 2022, the Company incurred shipping and handling costs in the amount of $1,026 and $40,254, respectively.

 

v3.23.3
OPERATING LEASE
9 Months Ended
Sep. 30, 2023
Operating Lease  
OPERATING LEASE

NOTE 3 – OPERATING LEASE

 

On January 18, 2019, the Company entered into an agreement to lease approximately 25,470 square feet of office and manufacturing space in Pompano Beach, Florida through March 2024. On March 25, 2019, the Company entered into an amendment to the agreement to increase the square footage of leased premises to 36,900 square feet, increasing the Company’s base rent obligation to be approximately $33,825 per month for one year and nine months, and increasing annually at a rate of three percent for the remainder of the lease term.

 

The right-of-use asset is composed of the sum of all remaining lease payments plus any initial direct costs and is amortized over the life of the expected lease term. For the expected term of the lease, the Company used the initial term of the five-year lease. If the Company does elect to exercise its option to extend the lease for another five years, for which the election will be treated as a lease modification, the lease will be reviewed for remeasurement.

 

On December 31, 2022 the Company and Landlord ended the lease agreement of the facility.

 

The future minimum lease payments to be made under the operating lease as of September 30, 2023, are zero.

 

On July 11, 2022, the Company entered into a sale leaseback transaction (the “Agreement”) with Quayco, LLC, a Pennsylvania limited liability company (the “Lessor”). The Company had previously ordered certain specialized BasaMax™ Pultrusion Machines (the “Machines”) from Upstate Custom Products LLC, a South Carolina limited liability company (the “Manufacturer”). The Machines are to be used to manufacture the Company’s basalt fiber reinforced polymer (BFRP) rebar products. Pursuant to the Agreement, the Lessor will pay the Company (Lessee) $450,000 and the Lessee will transfer to the Lessor secured rights to the ownership of one (1) BasaMax™ Tetrad Pultrusion Machine and all rights under the sales orders and agreements to purchase the Machines from Manufacturer. The Company had previously recorded this amount in accounts payable and construction in progress; at the date of the financing, the amount of $450,000 was transferred from construction in progress to a right of use asset and lease liability. The Company used a discount rate of 21% in calculating the lease liability and is the estimated rate the Company would be subject to for the financing of a similar equipment purchase. Pursuant to this lease, the Company will make payments in the amount of $8,250 per month for 24 months. 

 

v3.23.3
FINANCING LEASE – RELATED PARTY
9 Months Ended
Sep. 30, 2023
Financing Lease Related Party  
FINANCING LEASE – RELATED PARTY

NOTE 4 – FINANCING LEASE – RELATED PARTY

 

On April 27, 2022, the Company entered into an Equipment Rental Agreement (the “Agreement”) with First New Haven Mortgage Company, LLC, a Connecticut limited liability company and an affiliate of the Company (the “Lessor”). Ronald J. LoRicco, the Chairman of the Company’s Board of Directors, is the co-managing member of the Lessor and has an indirect pecuniary interest in the Lessor. In accordance with Nevada corporate law, the Agreement was independently reviewed and approved by the unanimous vote of the disinterested directors of the Company, with Mr. LoRicco recusing himself from voting.

 

Pursuant to the Agreement, the Lessor paid approximately $450,000 to Upstate Custom Products LLC, a South Carolina limited liability company (the “Manufacturer”) on April 22, 2022, to purchase a single, specialized BasaMax™ Tetrad Basalt Rebar Pultrusion Machine to be used to manufacture the Company’s products (the “Machine”). The Company had previously ordered the Machine from the Manufacturer, and pursuant to the Agreement, the Lessor secured rights to the ownership of the Machine and rights under all the sales orders and agreements to purchase the Machine from Manufacturer to the Lessor. The loan amount was paid directly to the Manufacturer. The Company used a discount rate of 21% in calculating the lease liability and is the estimated rate the Company would be subject to for the financing of a similar equipment purchase. Pursuant to this lease, the Company will make payments in the amount of $8,250 per month for 24 months, followed by a final payment in the amount of $450,000.

The Company has not yet received the machine in order to satisfy the transfer of the asset. As such, the $450,000 received from the transaction has been recorded as a liability on the balance sheet as of September 30, 2023 and December 31, 2022, respectively.

v3.23.3
NOTES PAYABLE
9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
NOTES PAYABLE

NOTE 5 – NOTES PAYABLE

 

Notes payable totaled an aggregate of $270,000 and $304,243 on September 30, 2023, and December 31, 2022, respectively. 

On February 25, 2021, the Company entered a promissory note agreement with a bank for $165,747 loan bearing an interest rate of 1.0% per annum. The loan was made pursuant to the Paycheck Protection Program under the Second Draw PPP Legislation after receiving confirmation from the U.S. Small Business Administration (“SBA”). The Paycheck Protection Program Flexibility Act requires that the funds be used to maintain the current number of employees as well as cover payroll-related costs, monthly mortgage or rent payments and utilities and not more than 40% can be expended on non-payroll-related costs. The applicable maturity date will be the maturity date as established by the SBA. If the SBA does not establish a maturity date or range of allowable maturity dates, the term will be five years. The Company applied for forgiveness of this loan on January 17, 2022; the Company received notice of forgiveness on August 1, 2022.

 

On April 2, 2021, the Company issued a promissory note with an investor in exchange for $200,000 bearing an interest rate of 18% per annum and payable in 1 year. The Company also issued 2,000,000 Common Stock warrants at an exercise price of $0.20 per share expiring in 5 years. As of September 30, 2023, the loan was extended to April 2, 2024.

 

On April 9, 2021, the Company issued a promissory note with an investor in exchange for $50,000 bearing an interest rate of 18% per annum and payable in 1 year. The Company also issued 500,000 Common Stock warrants at an exercise price of $0.20 per share expiring in 5 years. As of September 30, 2023 the loan was extended to April 9, 2024.

 

On April 16, 2021, the Company issued a promissory note with an investor in exchange for $25,000 bearing an interest rate of 18% per annum and payable in 1 year. The Company also issued 250,000 Common Stock warrants at an exercise price of $0.25 per share expiring in 5 years. As of the date of this report, the note has not been called. As of September 30, 2023 the loan was repaid in full and the balance is $0.

 

On April 16, 2021, the Company issued a promissory note with an investor in exchange for $20,000 bearing an interest rate of 18% per annum and payable in 1 year. The Company also issued 200,000 Common Stock warrants at an exercise price of $0.25 per share expiring in 5 years. As of September 30, 2023 the loan was extended to April 16, 2024.

 

The Company enters into financing arrangements for its liability insurance premiums. The financings have a term of one year and an interest rate of 9.40%. The balance due on these financings as of September 30, 2023 and December 31, 2022 $0 and $3,245, respectively.

 

Interest expense for the Company’s promissory notes payable for the three and nine months ended September 30, 2023 was, in the aggregate, $16,507 and $32,866, respectively, compared to $16,800 and $32,866 for the three and nine months ended September 30, 2022, respectively.

 

Accrued interest for the Company’s promissory notes payable on September 30, 2022 and December 31, 2022 was, in the aggregate, $147,062 and $101,391, respectively, and is included in accrued expenses on the accompanying condensed consolidated balance sheets.

 

v3.23.3
NOTES PAYABLE – RELATED PARTY
9 Months Ended
Sep. 30, 2023
Notes Payable Related Party  
NOTES PAYABLE – RELATED PARTY

NOTE 6 – NOTES PAYABLE – RELATED PARTY

 

Notes payable – Related Party, totaled an aggregate of $605,000 and $300,000 at September 30, 2022, and December 31, 2021, respectively.

 

On August 31, 2022 the Company issued a promissory note to a board member in exchange for $37,000 bearing an interest rate of 10% per annum and payable on August 31, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 31, 2024.

 

On August 22, 2022 the Company issued a promissory note to a board member in exchange for $20,000 bearing an interest rate of 10% per annum and payable on August 22, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 22, 2024.

 

On August 22, 2022 the Company issued a promissory note to a board member in exchange for $5,000 bearing an interest rate of 10% per annum and payable on August 22, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 22, 2024.

 

 

On August 29, 2022 the Company issued a promissory note to a board member in exchange for $25,000 bearing an interest rate of 10% per annum and payable on August 29, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 29, 2024.

 

On August 29, 2022 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 10% per annum and payable on August 29, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 29, 2024.

 

On August 31, 2022 the Company issued a promissory note to a board member in exchange for $13,000 bearing an interest rate of 10% per annum and payable on August 31, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 31, 2024.

 

On August 1, 2022 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 10% per annum and payable on August 1, 2024.

 

On September 9, 2022 the Company issued a promissory note to a board member in exchange for $60,000 bearing an interest rate of 10% per annum and payable on August 16, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of August 16, 2024.

 

On September 9, 2022 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 10% per annum and payable on September 9, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of September 9, 2024.

 

On September 9, 2022 the Company issued a promissory note to a strategic partner in exchange for $10,000 bearing an interest rate of 10% per annum and payable on September 9, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of September 9, 2024.

 

On September 9, 2022 the Company issued a promissory note to a strategic partner in exchange for $15,000 bearing an interest rate of 10% per annum and payable on September 9, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of September 9, 2024.

 

On September 9, 2022 the Company issued a promissory note to an investor and advisor to the board, in exchange for $15,000 bearing an interest rate of 10% per annum and payable on September 9, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of September 9, 2024.

 

On September 22, 2022 the Company issued a promissory note to a board member in exchange for $42,500 bearing an interest rate of 10% per annum and payable on March 22, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of March 22, 2024.

 

On September 22, 2022 the Company issued a promissory note to a board member in exchange for $42,500 bearing an interest rate of 10% per annum and payable on March 22, 2023. As of September 30, 2023 the note was extended for 1 additional year with a new maturity date of March 22, 2024.

 

On April 2, 2021, the Company issued a promissory note to Paul Sallarulo, a member of our Board of Directors, in exchange for $150,000 bearing an interest rate of 18% per annum and payable on April 2, 2022. The Company also issued a warrant to purchase 1,500,000 shares of Common Stock at an exercise price of $0.20 per share expiring in 5 years. On April 2, 2022, the due date of this note was extended to October 31, 2022. The note was extended for 2 additional years with a new maturity date of October 31, 2024.

 

On April 2, 2021, the Company issued a promissory note to Michael V. Barbera, our Chairman of the Board, in exchange for $150,000 bearing an interest rate of 18% per annum and payable on April 2, 2022. The Company also issued a warrant to purchase 1,500,000 shares of Common Stock at an exercise price of $0.20 per share expiring in 5 years. On April 2, 2022, the due date of this note was extended to October 31, 2022. The note was extended for 2 additional years with a new maturity date of October 31, 2024.

 

On February 14, 2023 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 20% per annum and payable February 14, 2024.

 

On February 24, 2023 the Company issued a promissory note to a board member in exchange for $50,000 bearing an interest rate of 20% per annum and payable February 24, 2024.

 

On April 12, 2023 the Company issued a promissory note to a board member in exchange for $150,000 bearing an interest rate of 20% per annum and payable April 11, 2024.

 

On April 28, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable April 27, 2024.

 

On May 12, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable May 11, 2024.

 

On June 5, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable June 4, 2023.

 

On July 25, 2023 the Company issued a promissory note to a board member in exchange for $200,000 bearing an interest rate of 20% per annum and payable on July 24, 2024.

 

On September 11, 2023 the Company issued a promissory note to a board member in exchange for $150,000 bearing an interest rate of 20% per annum and payable on September 10, 2024.

 

On September 11, 2023 the Company issued a promissory note to a board member in exchange for $50,000 bearing an interest rate of 20% per annum and payable on September 10, 2024.

 

During the three and nine months ended September 30, 2023, the Company made principal payments in the amount of $25,000 on notes payable.

 

Accrued interest for the Company’s notes payable - related party on September 30, 2022, and December 31, 2021, was an aggregate of $250,837 and $181,259, respectively, and is included in accrued expenses on the accompanying condensed consolidated balance sheets.

 

v3.23.3
NOTES PAYABLE – CONVERTIBLE – RELATED PARTY
9 Months Ended
Sep. 30, 2023
Notes Payable Convertible Related Party  
NOTES PAYABLE – CONVERTIBLE – RELATED PARTY

NOTE 7 – NOTES PAYABLE – CONVERTIBLE – RELATED PARTY (CONTINUED)

 

Convertible Notes payable – related party totaled an aggregate of $2,144,357 on September 30, 2023, and December 31, 2022 respectively.

 

On August 3, 2020, the Company issued a secured convertible promissory note to certain investors in exchange for $1,000,000 in the aggregate bearing an interest rate of 20% per annum and payable in 6 months. The holder may convert the unpaid principal balance of the note into shares of restricted Common Stock at the conversion price equal to $0.275 per share, which conversion price was set with the consummation of the Company’s private placement of Units which closed on August 17, 2021. This note contains a negative covenant that requires the Company to obtain consent prior to incurring any additional equity or debt investments and is secured by all of the assets of the Company. The Richard A. LoRicco Sr. and Lucille M. LoRicco Irrevocable Insurance Trust DTD 4/28/95, Louis Demaio as Trustee (the “Trust”) is the holder of $750,000 of the principal amount of this note. The Trust was created by Richard A. LoRicco Sr. and Lucille M. LoRicco, who were the parents of Ronald J. LoRicco Sr., the Chairman of the Company’s Board of Directors, and is maintained by an independent trustee. Ronald J. LoRicco Sr. does not have voting or investment control of or power over the Trust but is an anticipated, partial beneficiary of the Trust.

 

On February 12, 2021, the Company exchanged the original debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $1,610,005 bearing an interest rate of 20% per annum and fully payable in 3 months. This was accounted for as a debt extinguishment and the new promissory note was recorded at fair value in accordance with ASC 470 “Debt”. The original principal of $1,000,000 and accrued interest of $110,005 calculated as of the date of amendment and restatement along with an additional advance of $500,000 determined the principal amount of the new note. In consideration of the additional advance and the extension of the maturity date of the original note, the Company issued to the noteholders 5-year warrants to purchase an aggregate of 15,000,000 shares of Common Stock with an exercise price of $0.20 per share. The issuance of the warrants for the extension generated a loss on extinguishment of $3,686,123 for the fair value of the warrants issued.

 

On May 12, 2021, the Company extended the debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $1,689,746 bearing an interest rate of 20% per annum and fully payable February 12, 2022. The original principal of $1,610,005 and accrued interest of $79,742 calculated as of the date of amendment and restatement determined the principal amount of the new note. In consideration of the additional advance and the extension of the maturity date of the original note, the Company issued to the noteholders 5-year warrants to purchase an aggregate of 7,500,000 shares of Common Stock with an exercise price of $0.35 per share. The issuance of the warrants for the extension generated a loss on extinguishment of $1,874,705 for the fair value of the warrants issued.

 

On September 15, 2022, the Company extended the debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $2,027,695 bearing an interest rate of 20% per annum and fully payable February 12, 2023. The amended principal of $1,689,746 and accrued interest of $337,949 calculated as of the date of amendment and restatement determined the principal amount of the new note. No additional consideration was provided.

 

Interest expense for the Company’s convertible notes payable – related parties for the three and nine months ended September 30, 2023, was an aggregate of $107,218 and $321,654 respectively, compared to $45,371 and $276,228, respectively, for the three and nine months ended September 30, 2022.

 

Accrued interest for the Company’s convertible notes payable – related parties on September 30, 2023 and December 31, 2022, was an aggregate of $446,496 and $129,867, respectively, and is included in accrued expenses on the condensed consolidated balance sheets. 

 

v3.23.3
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

The Company is the obligor under certain promissory notes that are currently past due (although formal events of default have not been declared).

 

The Company is presently in default of its obligations under the terms of the Company’s private placement which closed in August 2021 to file a registration statement for an underwritten public offering and concurrently listing on a national stock exchange. As a result, the Company is required to pay liquidated damages in the amount of $53,345 per month starting in March 2022, and the maximum amount of such liquidated damages could be approximately $480,000 if such filing is not made.

 

On August 17, 2021, the Company conducted the closing of a private placement offering to accredited investors of the Company’s units at a price of $0.275 per unit, with each unit consisting of: (i) one share of the Company’s common stock, (ii) a five-year, immediately exercisable warrant (“Warrant A”) to purchase one share of common stock at an exercise price of $0.33 per share and (iii) an additional five-year, immediately exercisable warrant to purchase one share of common stock at an exercise price of $0.33 per share (“Warrant B”). The Warrant A and Warrant B are identical, except that the Warrant B has a call feature in favor of the Company, as defined in the offering agreements. In connection with the closing, the Company entered into definitive securities purchase agreements with 19 accredited investors and issued an aggregate of 19,398,144 shares of common stock, Warrant A to purchase up to an aggregate of 19,398,144 shares of common stock, and Warrant B to purchase up to an aggregate of 19,398,144 shares of Common Stock (for an aggregate of 38,796,288 Warrant Shares), for aggregate gross proceeds to the Company of approximately $5,334,490. Costs of the offering in the amount of $611,603 were charge to additional paid in capital. As of December 31, 2022 the Company also accrued the amount of $386,759 as liquidated damages due to the investors in the Company’s August 2021 private placement, such liquidated damages being related to the Company’s failure to timely file a registration statement on Form S-1 for an underwritten public offering and concurrent listing of the Common Stock on a national exchange.

 

v3.23.3
STOCKHOLDERS’ DEFICIT
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
STOCKHOLDERS’ DEFICIT

NOTE 9 – STOCKHOLDERS’ DEFICIT

 

During the nine months ended September 30, 2023, the Company issued 3,939,394 shares at $0.33 per share from subscription liabilities of $1,300,000 for cash that was received in a prior period.

 

 

v3.23.3
OPTIONS AND WARRANTS
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
OPTIONS AND WARRANTS

NOTE 10 – OPTIONS AND WARRANTS

 

Stock Options:

 

The following table provides the activity in options for the respective periods:

 

               
   Total Options   Weighted Average   Aggregate Intrinsic 
   Outstanding   Exercise Price   Value 
             
Balance at December 31, 2021   4,227,778   $0.33   $19,500 
Exercised   (500,000)   0.25    —   
Cancelled / Expired   (1,000,000)   0.55    —   
Balance at March 31, 2022   2,727,778)  $0.26   $   
Cancelled / Expired   (1,000,000)   0.25      
Balance at June 30, 2022   1,727,778   $0.27   $   
Exercised              
Balance at September 30, 2022   1,727,778   $0.27   $   

 

   Total Options   Weighted Average   Aggregate Intrinsic 
   Outstanding   Exercise Price   Value 
             
Balance at December 31, 2022   4,227,778   $0.33   $6,798 
Issued   (20,000,000)   0.27    —   
Cancelled / Expired   (750,000)   0.27    —   
Balance at March 31, 2023   1,477,778)  $0.27   $  
Cancelled / Expired        0.27      
Balance at June 30, 2023   1,727,778   $0.27   $   
Exercised              
Balance at September 30, 2023   1,727,778   $0.27   $   

 

Options exercisable and outstanding at September 30, 2023 are as follows:

 

                    
Range of  Number   Weighted Average Remaining Contractual   Weighted Average   Aggregate 
Exercise Prices  Outstanding   Life (Years)   Exercise Price   Intrinsic Value 
                 
$0.25 - $0.28   1,727,778    2.831   $0.27       
                    

 

Stock Warrants:

 

The following table provides the activity in warrants to purchase shares of Common Stock for the respective periods:

 

               
       Weighted     
       Average   Aggregate 
   Total Warrants   Exercise Price   Intrinsic Value 
             
Balance at December 31, 2021   138,191,666   $0.29   $3,824,750 
Granted   5,242,424    0.33    —   
Balance at March 31, 2022   143,434,090   $0.29   $1,147,100 
Granted   500,000    0.33      
Expired – cancelled   (2,045,000)   0.00      
Balance at June 30, 2022   141,889,090   $0.29   $204,000 
Granted   1,000,000    0.33    —   
Exercised   (1,333,333)   0.08      
Expired – cancelled   (1,500,000)   0.00    —   
Balance at September 30, 2022   140,055,757   $0.29   $150,667 
Balance at December 31, 2022   139,557,757   $0.29   $1,147,100 
Granted               —   
Cancelled               —   
Balance at March 31, 2023   139,557,757   $0.29   $1,147,100 
Granted                
Expired – cancelled   (7,342,000)          
Balance at June 30, 2023   132,215,757   $0.29   $150,667 
Granted               —   
Exercised               —   
Expired – cancelled   (5,920,000)   0.00    —   
Balance at September 30, 2023   126,295,757   $0.30   $150,667 

 

 

Warrants exercisable and outstanding at September 30, 2023 are as follows:

 

                      
        Weighted Average         
        Remaining         
Range of   Number   Contractual   Weighted Average   Aggregate 
Exercise Prices   Outstanding   Life (Years)   Exercise Price   Intrinsic Value 
                  
 $0.01 - $0.50    126,295,757    2.65    0.30   $150,667 
 $0.51 - $1.00          —               
      126,295,757             $150,667 

 

v3.23.3
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 11 – SUBSEQUENT EVENTS

 

 

On November 9th, 2023 the Company and its Interim CEO agreed to accrue a total of 50% of the monthly engagement fee of $16,666 for the remaining portion of the agreement which ends December 15, 2023. The full amount of the accrual will be paid to Mr. Richmond upon the Company receiving funding for the 2024 operations. The Company further agreed to pay Mr. Richmond a total of 20% interest per annum for a period of six months while the Company awaits funding for operations.

 

On or about September 15, 2023 the Company filed suit in the state of Florida for the ongoing lawsuit against UCP with regards to the completion of the equipment ordered in 2021. As of this filing the matter remains unresolved.

 

v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Use of Estimates in Financial Statements

(A) Use of Estimates in Financial Statements

 

The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Stock-based compensation and stock awards related to convertible debt instruments are recognized based on the fair value of the awards granted. The fair value of each award or conversion feature is typically estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions, including the fair value of the underlying Common Stock, the expected term of the option, the expected volatility of the price of our Common Stock, risk-free interest rates and the expected dividend yield of our Common Stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.

 

The Company used the Black Scholes valuation model to determine the fair value of the warrants and options issued, using the following key assumptions for the nine months ended September 30, 2022. There were no such valuations during the nine months ended September 30, 2023:

        
   Nine months   Nine months 
   ended   ended 
   September 30,   September 30, 
   2023   2022 
   (Unaudited)     
Expected price volatility  N/A   144.21-145.773% 
Risk-free interest rate  N/A   2.55-4.21 
Expected life in years  N/A   5 
Dividend yield  N/A   N/A 

 

Principles of Consolidation

(B) Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of Basanite, Inc. and its wholly owned subsidiaries, Basanite Industries, LLC and Basalt America, LLC. All intercompany balances have been eliminated in consolidation. The Company’s operations are conducted primarily through Basanite Industries, LLC. Basalt America, LLC is currently inactive.

 

Cash

(C) Cash

 

The Company considers all highly liquid temporary cash instruments with an original maturity of three months or less to be cash equivalents. The Company places its cash, cash equivalents and restricted cash on deposit with financial institutions in the United States, which are insured by the Federal Deposit Insurance Company “(“FDIC”) up to $250,000. The Company’s credit risk in the event of failure of these financial institutions is represented by the difference between the FDIC limit and the total amounts on deposit. Management monitors the financial institutions' creditworthiness in conjunction with balances on deposit to minimize risk. The Company from time to time may have amounts on deposit in excess of the insured limits.

 

Inventories

(D) Inventories

 

The Company’s inventories consist of raw materials, work in process and finished goods, both purchased and manufactured. Inventories are stated at lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. Raw materials inventory consists of basalt fiber and other necessary elements to produce BasaFlex™ rebar and our other products. On a quarterly basis, the Company analyzes its inventory levels and records allowances for inventory that has become obsolete and inventory that has a cost basis in excess of the expected net realizable value.

 

The Company’s inventory at September 30, 2023 and December 31, 2022 was (0) zero.

 

Fixed assets

(E) Fixed assets

 

Fixed assets consist of the following:

          
   September 30,   December 31, 
   2023   2022 
    (Unaudited)      
Computer equipment  $203,193   $203,193 
Machinery   728,245    728,245 
Leasehold improvements            
Office furniture and equipment            
Land improvements            
Website development            
Construction in process            
    931,438    931,438 
Accumulated depreciation and amortization   (497,205)   (401,200)
   $434,233   $530,238 

 

Depreciation expense for the three and nine months ended September 30, 2023, was $31,962 and $96,005, respectively; depreciation expense for the three months and nine months ended September 30, 2022, was $33,919 and $100,670, respectively.

 

Deposits and other current assets

(F) Deposits and other current assets

 

The Company’s deposits and other current assets consist of the deposits made on equipment, security deposits, utility deposits and other receivables. The deposits are reclassified as part of the fixed asset cost when received and placed into service.

 

Loss Per Share

(G) Loss Per Share

 

The basic loss per share is calculated by dividing the Company’s net loss available to common shareholders by the weighted average number of common shares during the period. The diluted loss per share is calculated by dividing the Company’s net loss by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.

 

The following are potentially dilutive shares not included in the loss per share computation:  

          
   September 30,   December 31, 
   2023   2022 
    (Unaudited)      
Options   1,477,778    1,477,778 
Warrants   126,295,757    139,555,757 
Convertible securities   8,016,068    8,016,068 
Total   149,799,603    149,389,507 

 

Stock-Based Compensation

(H) Stock-Based Compensation

 

The Company recognizes compensation costs to employees under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation – Stock Compensation. Under FASB ASC Topic 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the grant.

 

Revenue Recognition

(I) Revenue Recognition

 

We recognize revenue when control of the promised goods or services is transferred to the Company’s customers in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. The timing of revenue recognition largely is dependent on shipping terms. Revenue is recorded at the time of shipment for terms designated free on board (“FOB”) shipping point. For sales transactions designated FOB destination, revenue is recorded when the product is delivered to the customer’s delivery site.

 

All revenues recognized are net of trade allowances, cash discounts, and sales returns. Trade allowances are based on the estimated obligations. Adjustments to earnings resulting from revisions to estimates on discounts and returns have been immaterial for each of the reported periods. Shipping and handling amounts billed to a customer as part of a sales transaction are included in revenues, and the related costs are included in cost of goods sold. Shipping and handling are treated as fulfillment activities, rather than promised services, and therefore are not considered separate performance obligations. During the three and nine months ended September 30, 2023, and 2022, the Company incurred shipping and handling costs in the amount of $1,026 and $40,254, respectively.

 

v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of fair value of the warrants and options issued
        
   Nine months   Nine months 
   ended   ended 
   September 30,   September 30, 
   2023   2022 
   (Unaudited)     
Expected price volatility  N/A   144.21-145.773% 
Risk-free interest rate  N/A   2.55-4.21 
Expected life in years  N/A   5 
Dividend yield  N/A   N/A 
Schedule of fixed assets
          
   September 30,   December 31, 
   2023   2022 
    (Unaudited)      
Computer equipment  $203,193   $203,193 
Machinery   728,245    728,245 
Leasehold improvements            
Office furniture and equipment            
Land improvements            
Website development            
Construction in process            
    931,438    931,438 
Accumulated depreciation and amortization   (497,205)   (401,200)
   $434,233   $530,238 
Schedule of dilutive shares not included in the loss per share computation
          
   September 30,   December 31, 
   2023   2022 
    (Unaudited)      
Options   1,477,778    1,477,778 
Warrants   126,295,757    139,555,757 
Convertible securities   8,016,068    8,016,068 
Total   149,799,603    149,389,507 
v3.23.3
OPTIONS AND WARRANTS (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of option activity
               
   Total Options   Weighted Average   Aggregate Intrinsic 
   Outstanding   Exercise Price   Value 
             
Balance at December 31, 2021   4,227,778   $0.33   $19,500 
Exercised   (500,000)   0.25    —   
Cancelled / Expired   (1,000,000)   0.55    —   
Balance at March 31, 2022   2,727,778)  $0.26   $   
Cancelled / Expired   (1,000,000)   0.25      
Balance at June 30, 2022   1,727,778   $0.27   $   
Exercised              
Balance at September 30, 2022   1,727,778   $0.27   $   

 

   Total Options   Weighted Average   Aggregate Intrinsic 
   Outstanding   Exercise Price   Value 
             
Balance at December 31, 2022   4,227,778   $0.33   $6,798 
Issued   (20,000,000)   0.27    —   
Cancelled / Expired   (750,000)   0.27    —   
Balance at March 31, 2023   1,477,778)  $0.27   $  
Cancelled / Expired        0.27      
Balance at June 30, 2023   1,727,778   $0.27   $   
Exercised              
Balance at September 30, 2023   1,727,778   $0.27   $   
Schedule of options and warrants exercisable and outstanding
                    
Range of  Number   Weighted Average Remaining Contractual   Weighted Average   Aggregate 
Exercise Prices  Outstanding   Life (Years)   Exercise Price   Intrinsic Value 
                 
$0.25 - $0.28   1,727,778    2.831   $0.27       
                    
Schedule of warrants activity
               
       Weighted     
       Average   Aggregate 
   Total Warrants   Exercise Price   Intrinsic Value 
             
Balance at December 31, 2021   138,191,666   $0.29   $3,824,750 
Granted   5,242,424    0.33    —   
Balance at March 31, 2022   143,434,090   $0.29   $1,147,100 
Granted   500,000    0.33      
Expired – cancelled   (2,045,000)   0.00      
Balance at June 30, 2022   141,889,090   $0.29   $204,000 
Granted   1,000,000    0.33    —   
Exercised   (1,333,333)   0.08      
Expired – cancelled   (1,500,000)   0.00    —   
Balance at September 30, 2022   140,055,757   $0.29   $150,667 
Balance at December 31, 2022   139,557,757   $0.29   $1,147,100 
Granted               —   
Cancelled               —   
Balance at March 31, 2023   139,557,757   $0.29   $1,147,100 
Granted                
Expired – cancelled   (7,342,000)          
Balance at June 30, 2023   132,215,757   $0.29   $150,667 
Granted               —   
Exercised               —   
Expired – cancelled   (5,920,000)   0.00    —   
Balance at September 30, 2023   126,295,757   $0.30   $150,667 
Schedule of warrants exercisable and outstanding
                      
        Weighted Average         
        Remaining         
Range of   Number   Contractual   Weighted Average   Aggregate 
Exercise Prices   Outstanding   Life (Years)   Exercise Price   Intrinsic Value 
                  
 $0.01 - $0.50    126,295,757    2.65    0.30   $150,667 
 $0.51 - $1.00          —               
      126,295,757             $150,667 
v3.23.3
ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Accumulated deficit $ 55,680,904   $ 54,093,010
Working capital deficiency 7,112,084   7,033,031
Net Cash Provided by (Used in) Operating Activities 820,824 $ 907,494  
Cash $ 115,273   $ 30,340
v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Fair Value of Warrants and Options) (Details)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Expected price volatility 144.21%
Expected price volatility 145.773%
Risk-free interest rate 2.55%
Risk-free interest rate 4.21%
Expected life in years 5 years
v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Fixed assets) (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Fixed assets, gross $ 931,438 $ 931,438
Accumulated depreciation and amortization (497,205) (401,200)
Total fixed assets, net 434,233 530,238
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Fixed assets, gross 203,193 203,193
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Fixed assets, gross 728,245 728,245
Leaseholds and Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Fixed assets, gross
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Fixed assets, gross
Land Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Fixed assets, gross
Software Development [Member]    
Property, Plant and Equipment [Line Items]    
Fixed assets, gross
Construction in Progress [Member]    
Property, Plant and Equipment [Line Items]    
Fixed assets, gross
v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Dilutive Shares Not Included in Loss Per Share Computation) (Details) - shares
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive shares not included in loss per share computation 149,799,603 149,389,507
Equity Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive shares not included in loss per share computation 1,477,778 1,477,778
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive shares not included in loss per share computation 126,295,757 139,555,757
Convertible Debt Securities [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive shares not included in loss per share computation 8,016,068 8,016,068
v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Accounting Policies [Abstract]        
Cash insured amount $ 250,000   $ 250,000  
Depreciation expense 31,962 $ 33,919 96,005 $ 100,670
Shipping and handling costs $ 1,026 $ 40,254 $ 1,026 $ 40,254
v3.23.3
OPERATING LEASE (Details Narrative) - USD ($)
Mar. 25, 2019
Sep. 30, 2023
Operating Lease    
Base rent obligation $ 33,825  
Future minimum lease payments   $ 0
v3.23.3
FINANCING LEASE – RELATED PARTY (Details Narrative) - USD ($)
Apr. 27, 2022
Sep. 30, 2023
Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]      
Received from the transaction recorded liability   $ 450,000 $ 450,000
First New Haven Mortgage Company L L C [Member] | Upstate Custom Products L L C [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Related Party Transaction, Amounts of Transaction $ 450,000    
Lessee, Finance Lease, Discount Rate 21.00%    
Finance lease, periodic payment $ 8,250    
Finance lease, payment $ 450,000    
v3.23.3
NOTES PAYABLE (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Apr. 16, 2021
Apr. 09, 2021
Apr. 02, 2021
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Feb. 25, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Notes payable       $ 270,000   $ 270,000   $ 304,243  
Interest expense       16,507 $ 16,800 $ 32,866 $ 32,866    
Accrued interest         $ 147,062   $ 147,062 101,391  
Liability Insurance Premiums [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Interest rate           9.40%      
Balance due       0   $ 0   $ 3,245  
Small Business Administration [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Debt principal amount                 $ 165,747
Interest rate                 1.00%
Common Stock Warrants [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Debt principal amount $ 25,000 $ 50,000 $ 200,000 $ 0   $ 0      
Interest rate 18.00% 18.00% 18.00%            
Common stock warrants issued 250,000 500,000 2,000,000            
Warrants exercise price $ 0.25 $ 0.20 $ 0.20            
Debt instrument, term 5 years 5 years 5 years            
Common Stock Warrants 1 [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Debt principal amount $ 20,000                
Interest rate 18.00%                
Common stock warrants issued 200,000                
Warrants exercise price $ 0.25                
Debt instrument, term 5 years                
v3.23.3
NOTES PAYABLE – RELATED PARTY (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 11, 2023
Jun. 25, 2023
Jun. 05, 2023
May 12, 2023
Apr. 28, 2023
Apr. 12, 2023
Feb. 24, 2023
Feb. 14, 2023
Sep. 22, 2022
Sep. 09, 2022
Aug. 31, 2022
Aug. 29, 2022
Aug. 22, 2022
Aug. 01, 2022
Apr. 02, 2022
Apr. 02, 2021
Sep. 30, 2023
Sep. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Dec. 31, 2021
Offsetting Assets [Line Items]                                          
Notes payable - related party                                 $ 1,575,000 $ 1,575,000 $ 605,000 $ 605,000 $ 300,000
Notes payable                                 25,000 25,000      
Accrued interest                                 $ 250,837 $ 250,837 $ 181,259    
Promissory Note [Member]                                          
Offsetting Assets [Line Items]                                          
Face amount $ 150,000 $ 200,000 $ 100,000 $ 100,000 $ 100,000 $ 150,000 $ 50,000 $ 10,000 $ 42,500 $ 60,000 $ 37,000 $ 25,000 $ 20,000 $ 10,000              
Interest rate 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%              
Maturity date Sep. 10, 2024 Jul. 24, 2024 Jun. 04, 2023 May 11, 2024 Apr. 27, 2024 Apr. 11, 2024 Feb. 24, 2024 Feb. 14, 2024 Mar. 22, 2024 Aug. 16, 2024 Aug. 31, 2024 Aug. 29, 2024 Aug. 22, 2024 Aug. 01, 2024              
Promissory Note [Member] | Paul Sallarulo [Member]                                          
Offsetting Assets [Line Items]                                          
Face amount                               $ 150,000          
Interest rate                               18.00%          
Maturity date                             Oct. 31, 2024 Apr. 02, 2022          
Issuance of shares                               1,500,000          
Exercise price                               $ 0.20          
Maturity term                               5 years          
Promissory Note [Member] | Michael V Barbera [Member]                                          
Offsetting Assets [Line Items]                                          
Face amount                               $ 150,000          
Interest rate                               18.00%          
Maturity date                             Oct. 31, 2024 Apr. 02, 2022          
Issuance of shares                               1,500,000          
Exercise price                               $ 0.20          
Maturity term                               5 years          
Promissory Note 1 [Member]                                          
Offsetting Assets [Line Items]                                          
Face amount $ 50,000               $ 42,500 $ 10,000 $ 13,000 $ 10,000 $ 5,000                
Interest rate 20.00%               10.00% 10.00% 10.00% 10.00% 10.00%                
Maturity date Sep. 10, 2024               Mar. 22, 2024 Sep. 09, 2024 Aug. 31, 2024 Aug. 29, 2024 Aug. 22, 2024                
Promissory Note 2 [Member]                                          
Offsetting Assets [Line Items]                                          
Face amount                   $ 10,000                      
Interest rate                   10.00%                      
Maturity date                   Sep. 09, 2024                      
Promissory Note 3 [Member]                                          
Offsetting Assets [Line Items]                                          
Face amount                   $ 15,000                      
Interest rate                   10.00%                      
Maturity date                   Sep. 09, 2024                      
Promissory Note 4 [Member]                                          
Offsetting Assets [Line Items]                                          
Face amount                   $ 15,000                      
Interest rate                   10.00%                      
Maturity date                   Sep. 09, 2024                      
v3.23.3
NOTES PAYABLE – CONVERTIBLE – RELATED PARTY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
May 12, 2021
Feb. 12, 2021
Sep. 15, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Aug. 03, 2020
Short-Term Debt [Line Items]                  
Total aggregate value       $ 2,144,357   $ 2,144,357   $ 2,144,357  
The original principal     $ 1,689,746            
Accrued interest paid     $ 337,949            
Gain on extinguishment of debt       $ (6,743,015)    
Interest expense       16,507 16,800 32,866 32,866    
Secured Convertible Promissory Note [Member]                  
Short-Term Debt [Line Items]                  
Interest rate     20.00%            
Debt principal amount     $ 2,027,695            
Convertible Note Payable [Member]                  
Short-Term Debt [Line Items]                  
Interest expense       107,218 $ 45,371 321,654 $ 276,228    
Secured Convertible Promissory Note Agreements With Related Party [Member]                  
Short-Term Debt [Line Items]                  
Interest rate                 20.00%
Debt principal amount                 $ 750,000
Convertible Promissory Note Investors [Member]                  
Short-Term Debt [Line Items]                  
Interest rate 20.00% 20.00%              
Debt principal amount $ 1,689,746 $ 1,610,005              
The original principal 1,610,005 1,000,000              
Accrued interest paid $ 79,742 $ 110,005              
Warrants term 5 years 5 years              
Issued to the noteholders 7,500,000 15,000,000              
Exercise price $ 0.35 $ 0.20              
Loss on extinguishment   $ 3,686,123              
Gain on extinguishment of debt $ 1,874,705                
Convertible Notes Payable Related Party [Member]                  
Short-Term Debt [Line Items]                  
Accrued interest       $ 446,496   $ 446,496   $ 129,867  
v3.23.3
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2023
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]    
Liquidated damages $ 480,000 $ 53,345
Definitive securities purchase agreements, description the Company entered into definitive securities purchase agreements with 19 accredited investors and issued an aggregate of 19,398,144 shares of common stock, Warrant A to purchase up to an aggregate of 19,398,144 shares of common stock, and Warrant B to purchase up to an aggregate of 19,398,144 shares of Common Stock (for an aggregate of 38,796,288 Warrant Shares), for aggregate gross proceeds to the Company of approximately $5,334,490. Costs of the offering in the amount of $611,603 were charge to additional paid in capital. As of December 31, 2022 the Company also accrued the amount of $386,759 as liquidated damages due to the investors in the Company’s August 2021 private placement, such liquidated damages being related to the Company’s failure to timely file a registration statement on Form S-1 for an underwritten public offering and concurrent listing of the Common Stock on a national exchange.  
v3.23.3
STOCKHOLDERS’ DEFICIT (Details Narrative)
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Stock issued for cash | $ $ 1,300,000
Common Stock [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Stock issued for cash | shares 3,939,394
issued shares per share | $ / shares $ 0.33
v3.23.3
OPTIONS AND WARRANTS (Details) - Equity Option [Member] - USD ($)
3 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Offsetting Assets [Line Items]            
Outstanding at beginning 1,727,778 1,477,778 4,227,778 1,727,778 2,727,778 4,227,778
Issued     (20,000,000)      
Weighted Average Exercise Price, Beginning $ 0.27 $ 0.27 $ 0.33 $ 0.27 $ 0.26 $ 0.33
Weighted average exercise price, Issued     $ 0.27      
Aggregate Intrinsic Value, Beginning $ 6,798 $ 19,500
Exercised       (500,000)
Weighted Average Exercise Price, Exercised           $ 0.25
Cancelled / Expired   (750,000)   (1,000,000) (1,000,000)
Weighted average exercise price, Cancelled / Expired   $ 0.27 $ 0.27   $ 0.25 $ 0.55
Exercised       500,000
Outstanding at ending 1,727,778 1,727,778 1,477,778 1,727,778 1,727,778 2,727,778
Weighted Average Exercise Price, Ending $ 0.27 $ 0.27 $ 0.27 $ 0.27 $ 0.27 $ 0.26
Aggregate Intrinsic Value, Ending
v3.23.3
OPTIONS AND WARRANTS (Details 1) - Equity Option [Member] - Exercise Price Range One [Member]
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Offsetting Assets [Line Items]  
Range of Exercise Prices, Lower $ 0.25
Range of Exercise Prices, Upper $ 0.28
Number Outstanding | shares 1,727,778
Weighted Average Remaining Contractual Life (Years) 2 years 9 months 29 days
Weighted Average Exercise Price $ 0.27
Average Intrinsic Value | $
v3.23.3
OPTIONS AND WARRANTS (Details 2) - Warrant [Member] - USD ($)
3 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Outstanding at beginning 132,215,757 139,557,757 139,557,757 141,889,090 143,434,090 138,191,666
Weighted Average Exercise Price, Beginning $ 0.29 $ 0.29 $ 0.29 $ 0.29 $ 0.29 $ 0.29
Aggregate Intrinsic Value, Beginning $ 150,667 $ 1,147,100 $ 1,147,100 $ 204,000 $ 1,147,100 $ 3,824,750
Warrants granted 1,000,000 500,000 5,242,424
Weighted Average Exercise Price, Granted $ 0.33 $ 0.33 $ 0.33
Warrant Expired - cancelled (5,920,000) (7,342,000) (1,500,000) (2,045,000)  
Weighted Average Exercise Price, Expired - cancelled $ 0.00 $ 0.00 $ 0.00  
Warrant exercised     (1,333,333)    
Weighted Average Exercise Price, Exercised     $ 0.08    
Outstanding at ending 126,295,757 132,215,757 139,557,757 140,055,757 141,889,090 143,434,090
Weighted Average Exercise Price, Ending $ 0.30 $ 0.29 $ 0.29 $ 0.29 $ 0.29 $ 0.29
Aggregate Intrinsic Value, Ending $ 150,667 $ 150,667 $ 1,147,100 $ 150,667 $ 204,000 $ 1,147,100
v3.23.3
OPTIONS AND WARRANTS (Details 3) - Warrant [Member]
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number Outstanding | shares 126,295,757
Aggregate Intrinsic Value | $ $ 150,667
Exercise Price Range One [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Range of Exercise Prices, Lower $ 0.01
Range of Exercise Prices, Upper $ 0.50
Number Outstanding | shares 126,295,757
Weighted Average Remaining Contractual Life (Years) 2 years 7 months 24 days
Weighted Average Exercise Price $ 0.30
Aggregate Intrinsic Value | $ $ 150,667
Exercise Price Range Two [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Range of Exercise Prices, Lower $ 0.51
Range of Exercise Prices, Upper $ 1.00
Number Outstanding | shares
Weighted Average Exercise Price
Aggregate Intrinsic Value | $
v3.23.3
SUBSEQUENT EVENTS (Details Narrative)
Nov. 09, 2023
USD ($)
Subsequent Event [Member]  
Subsequent Event [Line Items]  
Monthly engagement fee $ 16,666

Basanite (QB) (USOTC:BASA)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Basanite (QB) Charts.
Basanite (QB) (USOTC:BASA)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Basanite (QB) Charts.